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ABSTRACT 
The way pharmaceutical industry develops and manufactures their products has been 
changing in recent years. The regulatory environment that they are obligated to comply has 
been pushing this change in order to endow this activity with state of art technology. The 
encouragement of the use of process analytical technology (PAT) to build the quality right 
from the design (QbD) is perhaps the most significant example of the new paradigm. The 
manufacturers are implementing this technology in new and existing products and benefiting 
from their advantages. 
To implement PAT in a process, many steps must be taken (from the study of feasibility 
of the instruments until regulatory approval). This thesis describes the initial study (feasibility 
and model developments), prior to any submission of authorization, of the use of PAT tools 
(Near-Infrared (NIR), Red Green Blue (RGB) camera and Light Induced Fluorescence (LIF)) 
to monitor the compression process of a commercial multi-component blend. 
After the potential of these tools was assessed, quantitative Partial Least Squares (PLS) 
models were able to be developed to monitor components with a concentration as low as 0.1 
w/w % with a R2 of 0.95. It was also proved that combining data from more than one tool was 
benefit for the accuracy of the model. The tools were also evaluated to their specificity by 
using a full factorial design where the models were built with simultaneous variations of 
concentration of some of the components. Even in this challenging case, the models built 
remained with an acceptable accuracy, considering the acceptance criteria used for dietary 
products such as multi-vitamins. 
The work developed in this thesis contributed to the publication of 3 articles and 3 
communications. Along with the proof of concept that it provided - which enlarged the 
opportunities for testing other probes - it also proved that is possible to monitor in-line the 
components in the feed frame. In this latter case, all the tools were accurate enough to monitor 
at least one component even if they are present in low concentration and part of multi-
component blends. 
Therefore, the industry can use this knowledge to monitor the compression process more 
adequately, increasing the range of tools used for the effect. Fundamental research can also be 
investigated as phenomena like segregation can be more accurately identified. 
Keywords: PAT, LIF, NIR, RGB, Compression, PLS 
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RÉSUMÉ 
 
La façon dont l'industrie pharmaceutique développe et manufacture ses produits a évolué 
au cours de ces dernières années. L'environnement réglementaire auquel elle est contrainte a 
provoqué ce changement dans le but de doter de technologies de pointe dans ses différentes 
activités. L’encouragement pour utiliser les technologies d’analyse de procédé (PAT) afin 
d’implémenter le concept de « Quality By Design » (QbD) est l’exemple le plus significatif de 
ce nouveau paradigme. Lentement, les industries implémentent ces technologies pour de 
nouveaux produits, mais également pour certains produits déjà existants, bénéficiant ainsi de 
leurs avantages.  
Pour implémenter des PAT dans un procédé, plusieurs étapes doivent être franchies, de 
l’étude de faisabilité des instruments jusqu’à l’approbation règlementaire. Cette thèse décrit 
l’étude initiale (faisabilité et développement de modèles) avant toute demande d’autorisation 
d’utilisation d’outils PAT (proche infra-rouge (NIR), caméra RGB et fluorescence induite par 
laser (LIF)) pour suivre le procédé de compression d’un mélange commercial comprenant 
plusieurs ingrédients. 
Après avoir établi le potentiel de ces différents outils, des modèles quantitatifs calculés 
par régression par moindres carrés partiels (PLS) ont été développés pour suivre les 
composants ayant une concentration aussi faible que 0,1 w/w%, avec un coefficient de 
détermination (R2) de 0,95. Il a également été démontré que l’utilisation conjointe de données 
de plus d’un outil améliorait la précision du modèle. La spécificité de chacun des outils a 
également été évaluée à l’aide de plan d’expériences factoriels complets pour lesquels les 
modèles ont été construits en faisant varier simultanément la concentration de différents 
éléments. Même dans ces conditions, les modèles construits ont montré une précision 
acceptable, en considérant les critères d’acceptation utilisés pour les produits alimentaires 
comme les multivitamines. 
Le travail présenté dans cette thèse a contribué à la publication de trois articles et de trois 
présentations orales. En plus de l’établissement de la preuve de concept, ce qui augmente les 
opportunités pour tester d’autres sondes, la possibilité de suivre en ligne la composition 
quantitative dans la ligne d’alimentation de la presse a également été établi. Dans ce dernier 
 cas, tous les outils sont suffisamment précis pour suivre au moins un des composants, même si 
celui-ci est présent en faible concentration et fait partie d’un mélange de plusieurs composants. 
 
Conséquemment, l’industrie peut utiliser ses connaissances pour suivre le procédé de 
compression de façon plus adéquate en augmentant l’éventail des outils utilisés à cet effet. 
Une recherche fondamentale pourrait également investiguer divers phénomènes tels que la 
ségrégation, afin de mieux les comprendre. 
 
 
Mots-clés: PAT, LIF, NIR, RGB, Compression, PLS 
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CHAPTER 1 INTRODUCTION 
1.1 Context and problem to solve 
Pharmaceutical industry is the subject of a strict legislation and regulation environment 
put in place to ensure that a quality product is delivered to the market. Regulatory agencies 
such as the Food and Drug Administration (FDA) in the United States, Health Canada and the 
European Medicine Agency, through the publication of checklists and guidelines, demand an 
extensive list of requirements right from the beginning of the development of a new 
pharmaceutical product up to post-commercialization monitoring. These demands require 
manufacturers to implement a system that facilitates the fulfillment of these requirements and, 
at the same time, to have the best possible tools to guarantee the production of a quality 
product while being able to keep economical competitiveness. Due to this regulatory 
environment and the difficult challenge that manufacturers face to fulfill it, a modification in 
the regulatory paradigm is not often promoted by the agencies, who have been historically 
conservative. In addition, a significant change in the processes, especially in products already 
approved, are also not promoted by manufacturers, which must follow the recommendations 
of their regulators and therefore are reluctant in submitting modifications in their already 
approved processes and products. This means that only a breakthrough event (new findings, 
new technology) by either part could lead to a significant change in the regulatory concepts 
and / or modifications of processes already approved. 
The implementation of Process Analytical Technologies (PAT) in pharmaceutics must be 
considered one of these events. Although their advantages had been recognized in many other 
industries before, once pharma regulatory agencies (especially the FDA) recommended their 
application, which converged with manufacturers growing will in adopting it, the paradigm 
changed significantly. At the same time the use of PAT triggered a new regulatory situation in 
which its application is critical to the fulfillment of requirements, scientists began studying 
and developing its use in many different processes, which has been leading to a boost in the 
PAT publications adapted to pharma. Therefore, the need to comply with the regulatory 
situation and the benefits for the manufacturer in applying PAT to their processes, concur for 
the pertinence of this work. 
  
 
2 
1.1.1 Regulatory context 
After the publication by the FDA of the guideline [1] that encourages the use of PAT in 
the development and manufacturing of pharmaceutical products, the way pharmaceutical 
industry has been working on their processes has changed. Along with the publication of 
Q8(R2) [2], Q9 [3] and Q10 [4] guidelines and later with Q11 [5], these documents drove 
pharmaceutical industry towards a new scenario in which the focus was no longer in the final 
product but in the knowledge and understanding of the processes, following a risk-based 
approach. The concept lies in the assumption that the risk should be identified, mitigated and 
continuously evaluated. As mentioned in Q8(R2), the information obtained throughout the life 
cycle of a product should be included in the process guaranteed by the quality system 
implemented by the manufacturer. Continuous improvement is a policy that must be followed 
in this industry. 
In this new paradigm, PAT plays a critical role as it allows gathering information in 
different steps that are critical to understand the underlying phenomena that are occurring. In 
this strategy, not only it helps in the identification of the risks but in their mitigation, 
monitoring, control and revaluation. In fact, it is intended to implement the concept of quality 
right from the early stages of development (Quality by Design (Qbd) [1]), in which a design 
space and a control strategy in the manufacturing stage are perfectly justifiable and a product 
is made within the defined specifications [6] limited by the control space (usually controlled 
by PAT tools). The advantages lie in the increase of safety and efficacy of the drugs and also 
in the efficiency of their manufacture chain as quality is improved and economical savings are 
obtained. This new paradigm was later reinforced through the publication of the guideline on 
process validation, in which the data coming from this technology could be used to validate 
the process [7]. The traditional approach of 3 batches validation is now complemented by 
what is called a continuous validation system. 
In spite of the attempt to adjust all the regulation to this new paradigm, the extensive set 
of documents ruling pharmaceutical activity that has not been updated, has raised issues about 
compliance when PAT is implemented, especially as monitoring tools. In fact, some of the 
requirements to control a batch are adjusted to the traditional techniques and thus, are 
inadequate to the PAT paradigm, which has been a drawback in its implementation. One of the 
typical examples occurred in tablet analysis. For many years it was only possible to comply 
  
 
3 
with the Uniformity of Dosage Units (UDU) test if 30 tablets were tested and no sample was 
outside the ± 25% of label claim. This statement did not take into account any statistical 
normal distribution and due to the larger number of samples obtained by PAT, the possibility 
of having a sample out of specification was very high. Therefore, until the implementation of a 
new regulation in March 2013 [8] that took into account the sampling size (chapter 2.9.47 of 
European Pharmacopeia – Demonstration of uniformity of Dosage Units using Large Sample 
Sizes), the use of PAT was somehow restricted in this case. Since a discussed strategy and the 
ultimate aim of this work is to confirm tablets conformity by analysing the powder that leads 
to their constitution, this chapter must be taken into account in a future implementation of the 
process. In the case some of the methods and recommendations stated in the regulatory 
guidelines are difficult to fulfill using PAT methods, the critical point is to guarantee quality 
of the product. Therefore, it is the manufacturer’s function to develop and prove that their 
methods are accurate and equivalent to the ones regulation considered to be the reference. 
 
1.1.2 Study of PAT in pharmaceutics 
Although the use of PAT in the development of new products allows taking full advantage 
of this technology, the application of PAT as a control tool in the manufacture of products 
which are already present in the market represents a valuable resource for this technology as 
well. For instance, the concepts of continuous manufacturing rely in the correct 
implementation of this technology throughout the manufacturing steps [9]. 
The implementation of techniques to monitor the critical quality attributes (CQA) of the 
product either by monitoring directly or through the control of the critical processes 
parameters (CPP) is never easy and comprises several steps. Due to the specificity of 
processes and products, it is hard to use methods beyond their intended use even if they were 
previously applied, since PAT usually depends on the development of a specific model for 
each case. However, previous knowledge might provide some hints of which CQAs / CPPs 
must be monitored, the tools that can be used and / or the restraints that must be considered. 
Since tablets are the most common pharmaceutical dosage form, the development of 
techniques that can be used to monitor their manufacturing steps (granulation, drying, 
blending or coating) has been the subject of several studies that are reported in the literature. 
On the other hand, not many studies have focused in the compression stage. In the literature, 
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monitoring of the compression stage has been divided in a) analysis of the intact tablet either 
in or off-line and b) monitoring the circulating powder in the feed frame of a press. The latter 
will be the focus of this work as many advantages can be listed. 
 
1.1.3 Advantages of monitoring the compression stage 
Despite the fact that the powder must be controlled in the preceding stages, especially its 
concentration and homogeneity, a fast and reliable measurement of its constitution at this 
stage might be important for several reasons. Thus, a simple identification of the components 
that constitute the powder entering the press machine might detect some errors occurring in 
previous stages, such as an error in formulation manufacturing (absence or wrong selection of 
a component, for instance). Although these episodes are rare, they can still occur, especially 
when a direct compression technique is applied, since it usually comprises just a simple 
mixing before compression. Another advantage lies in the possibility to quantify one or more 
components and guarantee the homogeneity of the powder that is delivered to the dies 
overcoming at the same time the identified problem of the representativeness of the sample 
obtained from thief sampling after blending [10]. In fact, identification of non-homogeneity 
whether segregation is present or not, is of the utmost importance at this stage. Moreover, the 
occurrence of the latter is potentiated during the transport to the hopper of the press and its 
discharge to the feed frame [11] (both are usually made by gravity). In addition, also 
contributing to this phenomenon is the mixing mechanism occurring inside the feed frame of 
the press [12], especially in multicomponent blends that due to their higher number of 
components, have a higher probability to have differences between them (especially particle 
size and shape). Thus, the use of monitoring tools might detect the occurrence of material that 
do not meet product specifications, allowing the person in charge to control the process, 
keeping the tablets under specification. A feedback control mechanism can be implemented 
based in the data obtained by these tools - for instance, through an installation of a controller 
that can stop immediately the press machine or in the case of continuous manufacturing, it can 
“communicate” with other equipment by adjusting their process parameters (speed rotation in 
a blender, for instance). The quantification of the component might also be used as a 
complement (in a first stage) to the uniformity dosage unit (UDU) test, usually performed at 
the end of the batch. As batch historical data is obtained, the suppression of this test by 
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traditional methods such as Ultra-Violet (UV) or High Performance Liquid Chromatography 
(HPLC), which are costly and do not provide immediate results, might be considered. This 
will allow the manufacturer to release the product immediately after manufacturing - Real 
Time Release – RTR (assuming the criteria for acceptance is met after analysis of data 
obtained through PAT tools) [13]. The quantification of the components to ensure the 
homogeneity of the blend is even more important when a certain Active Pharmaceutical 
Ingredient (API) with a narrow therapeutic margin is present (usually in low concentrations). 
The adequate monitoring allows important ensuring in the clinical safety for these types of 
formulations. Another advantage lies in the improvement in terms of quality that the 
implementation of PAT tools represents at this stage due to sampling available for the entire 
batch. In fact, regulation obligates the manufacturer to test up to 30 tablets (usually taken at 
different times during the batch) to evaluate their UDU [14] if traditional methods are used, 
independently of the number of tablets produced by batch. In this technique, since the powder 
present in the feed frame is subject to continuous analysis from the tools in place, it is possible 
to assess the uniformity required for the tablets. Moreover, in terms of the total mass of 
powder tested (in comparison with the sum of the mass of the 30 tablets required by 
regulation) and also in terms of the limit of 25 previously mentioned it is possible to test a 
larger quantity in comparison with traditional methods, allowing a stricter control of the 
quality of the batch [8] (consult Annex A.1 for the calculation in this case).  
Due to the benefits listed above, a need to develop a technique to monitor effectively the 
powder in the compression stage is perfectly identified. Although the specificity for a product 
is recognized, the evaluation of the proposed set-up and the potential of the selected 
monitoring tools to be used in PAT field can be extrapolated and might represent a 
breakthrough in the monitoring of this manufacturing step. 
 
1.1.4 Implementation of a PAT process 
The implementation of a PAT analytical technique intended to monitor and control a 
process goes through different stages. The first step is the recognition of the parameter, or 
attribute, to be monitored. Based on its characteristics and on the features of the analytical 
technique, a tool is proposed and a feasibility test must be performed (a preliminary test whose 
goal is to confirm the potential of the tool to monitor the parameter or attribute). The 
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following step includes the qualification of the analytical technique (installation, operation and 
performance). During this stage, analytical standards are used and the stability of the 
analytical technique must be assessed. For NIR, the wavelength and photometric scale must be 
validated [15] and parameters such as wavelength uncertainty, photometric linearity and 
spectrophotometric noise must be determined. Once the equipment is qualified, the method 
must be validated, that is, it must “demonstrate that the analytical technique is suitable for the 
intended purpose” [15]. Parameters such as specificity, linearity, range, accuracy, precision 
and robustness must be evaluated. These parameters are usually assessed using analytical 
reference data and statistics. The model for the parameter in study must be developed with an 
adequate design, to guarantee its robustness and after validation, it can be submitted to the 
regulator. Due to its paradigm, the PAT monitoring process is considered a continuous 
validation process. 
In this thesis, only the first part of this process (feasibility test) is developed. The models 
developed in this thesis are part of this stage and are not intend to be used for any type of 
submission. 
 
1.2 Definition of the research project 
 As mentioned in the previous section, the development of a methodology (proposed 
set-up, tools, data acquisition and analysis strategy) that can accurately monitor in real time 
the concentration of powder in the feed frame of a tablet press, is of the utmost importance, 
not only because of the regulatory demand but also due to the advantages listed. The objective 
of this thesis is: to use PAT tools as a process control strategy. Three different analytical 
techniques are proposed: Near-Infrared (NIR) spectroscopy, Light Induced Fluorescence (LIF) 
and Red Green and Blue (RGB) Imaging (camera), installed in the feed frame of a press 
machine and constituted by two intermeshing wheels. In a configuration like this, one of the 
wheels is responsible to immediately direct the powder that falls under gravity from the 
hopper into the feed frame to the dies, while the other recirculates the exceeding powder and 
ensures the filling requirements of the dies. Wahl et al. [16] stated that due to the larger 
residence time, the powder that reaches the second wheel has been more stressed and therefore 
is more likely to suffer phenomena like de-mixing and segregation. For these reasons, the 
authors considered that spectra of the powder obtained over the first wheel are more 
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representative of the constitution of the tablet and therefore, the probes must be placed in this 
position. However, since segregation is more likely to occur over the second wheel, placing 
the probes at this location might ensure product uniformity throughout the batch. In this work, 
the design of the press machine, specifically the position of the feed frame, made it impossible 
to install the probes over the first wheel and, therefore, the PAT tools were installed over the 
second wheel. A trigger was installed in the set-up, so the area of analysis remained the same 
to: a) mitigate the effect of potential variation due to the change of properties of the powder 
that can occur due to higher shear stresses (particle size and shape) and b) to remove any 
biased data that could happen due to paddle detection (especially in spectroscopic tools – 
although its influence is usually removed by pre-processing methods). 
Throughout this thesis, these analytical techniques were selected to monitor the 
concentration of 5 selected ingredients in a multicomponent / vitamin blend immediately 
before being compressed into tablets, which therefore gives a reasonable assumption of the 
constitution of the tablet. Considering previous studies that highlight potential segregation 
phenomena that might occur in this stage (see Section 2.2) and the potential replacement or 
reduction of final tablet testing (for example, UDU testing), quantification of the ingredients is 
of the utmost importance. Since it is not feasible to monitor all the 31 components of the 
blend, the components selected were the vitamins ascorbic acid, beta-carotene and riboflavin 
and the supplements ferrous fumarate and ginseng extract (Figure 1.1). 
                a)                                                          b)                                                      c) 
  
 
 
 
 
                                            d)                                                           e) 
Figure 1.1: Chemical structure of the components to monitor: a) ascorbic acid; b) beta-carotene; c) 
riboflavin; d) ferrous fumarate; e) ginsenoside (major constituent of ginseng) 
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They were selected based on their properties and the characteristics of the tools. Analysis of 
the chemical structure shows several O-H (ascorbic acid, riboflavin, ginseng), N-H 
(riboflavin) and C=O (ascorbic acid, riboflavin, ferrous fumarate) bonds, which are usually 
seen in NIR. It also shows some constituents with several aromatic rings (riboflavin, ginseng) 
that are usually seen by LIF and some of them present a distinguishable color (yellow for 
riboflavin, reddish brown for beta-carotene and ferrous fumarate and light brown for ginseng). 
The decision to monitor the concentration of the components and not any other parameter was 
due to the fact that at this stage, the concentration (and therefore, homogeneity) of the blend is 
usually an identified CQA. These will allow guaranteeing tablet uniformity and ensuring with 
more safety that UDU for these components is met throughout batch manufacture. 
Although this commercial blend is not regulatory considered to be a pharmaceutical 
product, its manufacture obeys to pharmaceutical requirements. For the purpose of this study, 
it is more adequate than a traditional pharmaceutical formulation due to the number of 
ingredients it has on its constitution. In fact, the complexity of the blend chosen to be 
monitored, allows extrapolating these findings to simpler cases in which less components are 
present (if these tools are successfully used to monitor these components in a complex blend, 
in cases where the number of components is lower – which is the case of the majority of 
pharmaceutical dosage forms - it is expected to perform even better). Moreover, since it is a 
complex blend and it is impossible to track all the components, marker constituents might be 
defined to extrapolate the monitoring to other components. In addition, the possibility to use 
more than one tool simultaneously for the same process was evaluated. This factor is of the 
upmost importance because many situations might require more than one monitoring tool: in 
cases where the formulation has more than one component required to be monitored (i.e., a 
formulation with more than one API) that are not responsive to the same tool; in the case 
different CQA are required to be monitored (i.e., the concentration of a component and 
humidity level of the mixture). For the purpose of this work it is also intended to evaluate if 
the simultaneous monitoring of a component by more than one tool, enhances its prediction 
and the advantages that come from their simultaneous use. At the same time, this work also 
assesses the potential of these PAT tools to work in-line, in this manufacturing stage or in any 
other, if the required conditions for these tools to work, are met (the component must be NIR 
responsive, fluorescent and show a distinctive color, respectively). 
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1.3 Project goals 
This thesis has one general objective that can be decomposed in several secondary 
objectives (defined in bullets): 
Develop a methodology that is able to accurately monitor in-line the concentration of the 
powder inside the press machine: 
 Investigate the feasibility and potential of a set-up to be used in the in-line monitoring 
of the compression process; 
 Investigate the potential of RGB camera and LIF tool (NIR had already been studied) 
to work as a PAT tool in the in-line monitoring, specifically in a feed frame of a press; 
 Develop models and test their robustness for selected components that can accurately 
predict their concentration, even for low dose components; 
 Propose strategies that can improve the accuracy of those models, mainly through 
chemometric techniques (ex: combining data from several tools); 
 Draw conclusions about the extrapolation to other processes, taken into account the 
conditions of this project, mainly the multicomponent /vitamin constitution of the powder 
used; 
 Evaluate the capacity of the tools to study the kinetics of the powder; 
 
1.4 Original contributions 
This project produced 3 different papers which included some original contributions:  
Demonstration and suggestion of the practical applicability of LIF and RGB camera in 
the in-line monitoring of the compression stage: Although NIR was also used in this project, 
its applicability as a PAT tool in many other processes and at this stage of the manufacturing 
process is well known (most of the PAT monitoring in the literature is done using NIR). 
Nevertheless, the in-line NIR probe used in this project had never been used to monitor a 
complex blend. On the other hand, the in-line applicability of LIF is a novelty in this project as 
well as the use of a RGB camera used in-line at this manufacturing stage. Taking advantage of 
the different features of the components present in the selected blend (the distinguishable color 
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of the component, necessary to be detected by the RGB camera or their fluorescent properties 
which is critical for LIF use) it was possible to show the utility of these tools in the PAT 
context. 
Possibility to quantify in-line low dose components in a feed frame of a tablet press even 
for multicomponent blends: Low dosage component quantification is a difficult task even for 
off-line techniques, which usually involves sample preparation to isolate the components 
intended to be quantified. The difficulty of that measurement increases when that component 
is present in a multicomponent blend due to signal interference. The possibility that such a 
concentration can be detected in-line is a breakthrough in process monitoring and opens the 
possibility that RTR can be applied in blends that have these types of components, for 
instance, contraceptive medicines. In this project, among the tools used, LIF demonstrated to 
be a suitable tool in monitoring low dosage component. 
Demonstration of the benefits of using simultaneous tools in the monitoring of one 
component: The PAT studies reported in the literature are usually presented by testing a single 
tool to monitor a certain parameter (or CQA). In this project, the usefulness of combining two 
or more tools was demonstrated, since the accuracy of the models developed for quantification 
of the components was improved when data from both tools were combined. This fact might 
be especially relevant for complex blends and for low dosage components if the tools are not 
sufficiently responsive to the component they intend to monitor. 
 
1.5 Document plan 
This thesis is divided in two different parts: State of art and project development. 
In the first part (chapter 2), some critical concepts used throughout this thesis are 
introduced, followed by a state of art review relatively to the PAT tools used in the work. 
Taking into account the nature of this project, the work that has been done on the compression 
stage is highlighted. 
The second part, which comprises the project development is constituted of three different 
chapters (3, 4 and 5). In chapter 3, a qualitative evaluation of the potential of the tools to 
detect changes in concentration is performed. Thus, it is intended to confirm the suitability of 
these tools and to validate the set-up by ensuring that the position where these tools were 
installed (feed frame) was adequate to detect those variations. Chapter 4 is intended to 
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evaluate the behavior of these tools in a real scenario, since the data was obtained in a running 
commercial (deactivated) press, using for the effect a marketed multicomponent blend. The 
quantification models of some of the components, the benefits of combining data obtained 
from more than one tool and the dynamics of the powder inside the feed frame were also 
assessed. Finally, in chapter 5, it is intended to evaluate the selectivity of each tool, 
considering concomitant interference between components. Thus, quantification models of 
these components were developed to evaluate their robustness when present in a complex 
blend. 
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CHAPTER 2 STATE OF ART 
This project encompasses many interrelated concepts. One of them is the link between 
PAT applications and Multivariate Data Analysis (MVDA) due to the amount of data that is 
generated through this technology and the benefits of interpreting them through mathematical 
strategies. The first part of this chapter provides the concepts that are necessary to understand 
this work. Therefore, the basics of chemometric techniques (section 2.1.1) that will be used in 
this thesis are presented, followed by the concepts of the PAT tools used (section 2.1.2). The 
mathematical transformation required in imaging analysis is highlighted. Finally, and taking 
into consideration the overall goal of the project (that is, in-line monitoring of the compression 
stage by installing in the press feed frame three different tools – NIR, RGB camera and LIF), 
the PAT application of these analytical techniques is reviewed, with special emphasis on their 
use at the compression stage (when reported). 
 
2.1 Background 
2.1.1 Chemometrics 
The amount of information obtained from various analytical techniques, whether they are 
“off” (“sample analyzed away from the process”), “at” (“sample analyzed in closed proximity 
to the process”), “on” (“sample is diverted from the process and may return after being 
analyzed”) or “in” (“sample is not removed from the process”)-line in a process [17], brought 
a “problem” to the pharmaceutical industry: its analysis. The development of tools allowing 
the establishment of some relations between the studied variables and / or their relation with 
the final product, became important to accurately determine the analyzed parameters, speed up 
the process and take full advantage of the PAT benefits. So, chemometrics became part of the 
pharmaceutical industry world, as its concept not only relate to the use of statistical methods 
for reduction and extraction of useful information present in multivariate data that can be used 
to monitor and predict specifications, but also to the capability to design and select optimal 
measurement procedures and experiments [18]. Thus, chemometrics are useful to detect 
relationships between process attributes and final product specifications, enhancing process 
understanding which leads to an efficient control of pharmaceutical processes [19]. 
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Several chemometric techniques have been developed in recent years [20]. These 
techniques are much more important as they extract quality information that can be used for 
the manufacturer to assure final product quality. The advantage of monitoring a 
pharmaceutical process is not only to comply with the quality assurance (QA) requirements, 
but also to allow the manufacturer to continuously verify that the process follows the predicted 
course, comparing it to a previously validated model and to modify the process in due time if 
something unexpected occurs. The following topics cover the chemometric techniques that 
will be used throughout this work. 
 
2.1.1.1 Multivariate Data Analysis and Regression Methods 
The huge amount of data that analytical techniques provide makes it necessary to 
implement some mathematical strategies in order to analyze them. The development of a 
model that must be validated before being industrially applicable and that will allow that a 
certain parameter or specification can be predicted, is one of the goals of data treatment.  
When different variables are present, one of the most used mathematical regression 
approaches is the Multi Linear Regression (MLR), where the independent variables predict the 
parameter(s) in study (dependent variable(s)), according to Equation 2.1: 
 
𝑦 = 𝑏0 +  𝑏1𝑥1 +  𝑏2𝑥2 +  … 𝑏𝑖𝑥𝑖  Equation 2.1 
 
where y = dependent variable; bi = regression coefficient; xi = independent variable 
 
However, this technique is not appropriate when dealing with the kind of information 
usually obtained by PAT tools, since in these cases, many variables either are correlated or 
influence each other, leading to an unreliable prediction of the y. Therefore, the use of latent 
variable models, which consist of data reduction through the establishment of relations 
between variables, is usually the resource used, making MVDA one of the most important 
strategies in this area. The combination of  the variables present in original data infers 
mathematically the formation of a lesser number of variables called “Latent Variables” (LV) 
which is precisely the foundation of data reduction [21]. This consists in reducing the original 
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data variables (xi) by establishing relationships between them. The LV formed are orthogonal 
between each other, that is, uncorrelated. 
Data are typically presented in an X matrix where the rows (M) represent the observations 
(samples), and the columns (N) represent the variables in the study (in a NIR spectrum, the 
wavelength). The parameter to be predicted is represented in another matrix (Y) which can be 
constituted of one or more variables, depending on the number of parameters to be predicted 
and the correlation between them. Usually, parameters that do not show a good correlation are 
predicted individually to increase the robustness of the model for each one of these 
parameters. 
When working with images, the previous concepts are applied in a special way and are 
referred to as Multivariate Image analysis (MIA). In this concept, data are acquired in image 
format and useful information is extracted by using MVDA concepts. 
This chapter presents the main concepts of three of the most applied techniques of MVDA 
which will be used throughout this project. 
 
Principal Component Analysis and Principal Component Regression 
Principal Component Analysis (PCA) is one of the first evaluations when dealing with 
MVDA. It is formed by building a vector in the X (M×N) matrix that explains most of the 
variance, that is, a vector that crosses all dimensions of data (variables) in a plane and lies in a 
position where the overall distance of the points to that vector is the smallest possible - first 
Principal Component (PC). Since there are points below and above the plane, this distance is 
computed as a sum of squares. The second PC is the vector that explains the following major 
source of variance of the data (although smaller than the first one), and so on, being all PC 
components orthogonal to each other (Figure 2.1 a) and b)). Therefore, the last PC represents 
little information, which is regularly considered as unimportant (noise) to the set. Extracting 
this part of the information leads to a reduction of the matrix rank, where the number of 
columns is the same as the number of PC chosen to characterize data, facilitating data 
interpretation. The maximum number of PCs that can be represented is given by the number of 
objects -1 or by the number of variables (depending on which one is smaller). 
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Figure 2.1: PCA design a) 3-Dimensional data set; b) the three first PCs; c) score plot of the first two 
PCs [22] 
 
The coefficients for the new variable vectors are the loadings (pi) (see Equation 2.2). 
When gathered, all the loadings constitute a matrix P (N×K), (K = number of components), 
which results from the transformation of the original data set relating to the variables. When 
projected in a loading plot, the relation of the variables with the PCs might be observed. 
Also in this mathematical development, the distance of every object (rows) to the vectors 
(PCs) (columns) that better explains the variance is calculated. This distance is called scores 
(t) and when gathered, they constitute the matrix T (M×K). Their representation is plotted in a 
score plot (Figure 2.1 c)). In this graph, the relations between the objects and how they behave 
against the PCs can easily be seen. 
Therefore, the X data are represented by Equation 2.2 [23]: 
 
 𝑿 = 𝑻 ∗ 𝑷′  +  𝑬 Equation 2.2 
 
where T = matrix of scores (M×K), P = matrix of loadings (N×K), E = matrix of noise 
(M×N), calculated after subtracting the original matrix by the matrix originated after chosen 
PCs were considered. 
 
The product of T and P’ is equal to the sum of the considered PCs, that is 
 
 𝑿 =  𝑡1 ∗ 𝑝1
′  +  𝑡2 ∗ 𝑝2
′ +  𝑡𝛼 ∗ 𝑝𝛼
′ + . . .  𝑬       Equation 2.3  
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where tα = scores of PCα and pα = loading of PCα. 
 
 Data mining 
PCA is intimately linked with data reduction, which is possible due to the properties of 
the matrixes, mainly the concepts of eigenvalues and eigenvectors. Although there are other 
mathematical techniques for data reduction, the most common are singular value 
decomposition (SVD) and nonlinear iterative partial least squares (NIPALS). The first, which 
is an adaptation for rectangular matrixes of the eigendecomposition for square matrixes, 
decomposes a matrix into the following equation: 
 
𝐴 = 𝑃𝛥𝑄𝑇  Equation 2.4 
 
Where A = rectangular matrix; P = normalized eigenvectors of AAT; Δ = diagonal matrix of 
the singular values (Δ = Ʌ0.5, Ʌ = diagonal matrix of the eigenvalues of matrix AAT and ATA); 
Q = normalized eigenvectors of ATA. 
 
The scores (T) and loadings (P) of equation 2.2 are related to “PΔ” and “QT” of equation 
2.3, respectively. This highlights the importance of calculating the eigenvalues / eigenvectors 
of matrixes. 
As NIPALS is concerned, it is more often used for large amounts of data and when only a 
few PCs are needed, since no covariance matrix is calculated. The description of the algorithm 
is present in section A.2. 
  
Therefore, PCA technique is useful for reducing the X data, removing the noise from it 
and allowing the observation of the relations between objects, overcoming the limitation of 
MLR when there is the need for a certain y parameter or specification to be predicted. In this 
case, this regression method is named Principal Component Regression (PCR) and it is a two-
step procedure, being the first the PCA transformation of the X matrix followed by the 
application of the MLR mode [23]. However, since the PCA application is independent from 
the y, this is, the model of fitting X could be different from the prediction ability of y, it is 
necessary to increase the number of PC one by one and test the model in order to have a good 
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predictability, which obviously limits the goal of truncating data. Therefore, a new regression 
method is more adequate and it is presented in the following section.  
 
 Partial Least Squares 
Partial Least Squares (PLS) method relies on the concept of PCA, but since it is a 
regression method, a Y matrix comprised of one or more parameters in study (the ones to be 
predicted) is added to the equation. This method differs from PCR because in the X matrix 
transformation, there is a maximization of covariance between the X and Y matrixes. In the 
mathematical development of this algorithm, other matrixes come into play, such as the 
loading weight (w) as well as the loadings (q) and scores (u) of the Y matrix. For a detailed 
explanation of the mathematical development of this equation, reference must be consulted 
[24]. 
The results of PLS produce the percentage of variance explained for the Y matrix, as well 
as the information used to achieve it in X data. A high percentage of the Y explained with a 
low percentage of X data used, represents a major goal of modeling using chemometrics and 
allows a good prediction of the parameter in study. However, these results could only be 
obtained if the relation between the variables of X data is strong enough. 
In some cases, the data used to predict the parameter Y can be obtained from more than 
one source (two different equipment, for example). In these cases, it is common to merge these 
sets of data in only one larger X matrix. However, it can be beneficial to use a different 
chemometric technique, which is described in the next section. 
 
 Multiblock 
With the variety of tools available and the possibility to include historic measurements in 
the study of a process (usually manufacturers keep some records that might be useful in the 
development of a model), there are many sources of data (different equipment used - NIR, 
LIF, traditional techniques, etc.) which generates different type of information that must not be 
interpreted as being part of each other, although it was obtained from a sample of the same 
composition. Thus, if the origin of the information is known, it is useful to apply a technique 
that segments data in blocks. Based on this, Consensus PCA (CPCA) and multiblock PLS 
(mbPLS) have been reported as good algorithms to work with, at least as a complementary 
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tool for traditional PCA and PLS. For a more detailed explanation of this algorithm, section 
4.2.6,  Figure 4.4 and the reference must be consulted [20]. MbPLS allows the inclusion of all 
types of information in a single matrix, although the mathematical development is able to 
separate it in blocks or segments. Although the overall prediction of the model is not improved 
when compared to PLS [25], the interpretation of the contribution to each block to the 
prediction of the Y is of the utmost importance, especially in the development stage and / or 
when more than one process tool is being tested, as it is the case in this project. 
However, even if better and more adequate methodology is applied, there is no certainty 
that a model could be successfully developed. In fact, model building involves lots of steps, 
which are detailed in the following section. 
 
 Modeling 
Building a model based in MVDA requires lot of data and an adequate extraction of its 
useful features. Several steps are usually recommended to be followed: 
 
 Exploratory data analysis 
It is the first step in model building and consists of the first overview of data, identifying 
the relation between the objects and variables. It is important for outlier detection, which is 
defined as a sample that differs strongly from the others. In model building, a negative effect 
will occur and inaccurate predictive results might occur [19]. Outlier identification in spectra 
is based in Leverage (position in relation to other samples) and Q-residuals (referred below). 
Regarding the y parameter, the y residual student test is usually performed. Outlier 
identification could also be performed in the following step of modeling which is the pre-
processing stage (confirms the suspicious samples and / or identifies newer ones). The 
complementary identification in these steps is critical for outlier detection and removal. 
 
 Data pre-processing 
Pre-processing is a crucial step in model building, performed to highlight the 
characteristics of the data facilitating its analysis, and also to correct some differences between 
samples attributed to factors other than their composition (i.e. equipment characteristic or 
powder difference - particle size, etc.). As an example, in spectroscopy, phenomena like 
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baseline offset and multiplicative effects are common. Preliminary observation of data allows 
the selection of an area of interest (in a spectrum, for example), which is also part of the pre-
processing. 
There are many types of pre-processing techniques that might be applied (individually or 
in combination). Their selection depends almost exclusively on the type of data being studied. 
One of the most used is autoscaling, which is calculated based in the following equation: 
 
𝑥𝑖𝑘
∗ =  
𝑥𝑖𝑘− ?̅?𝑘
𝑆𝑘
  Equation 2.5 
where 𝑥𝑖𝑘 = variable of index i (row) and k (column); ?̅?𝑘 = column mean; 𝑆𝑘 = √∑
𝑥𝑖𝑘−?̅?𝑘
𝑁−1
𝑁
𝑖=1  
 
Autoscaling is useful to remove the influence of absolute values and variation difference 
along the variable, thus, enhancing the variation response between them. This treatment is 
mandatory when working with variables whose values have different scales or orders of 
magnitude. 
Spectra are perhaps one of data types where pre-treatment is more important. Apart from 
selection of appropriate bandwidth (which some authors consider also part of data pre-
treatment), some corrections might need to be done. Phenomena such as multiplicative 
variations between spectra may be solved using techniques like standard normal deviation 
(SNV) – Equation 2.6 - or multiplicative signal correction (MSC) – Equation 2.7 [26][27]. 
 
𝑥𝑖𝑘
∗ =
(𝑥𝑖𝑘− 𝑚𝑖 )
𝑆𝑖
 Equation 2.6 
𝑥𝑖𝑘
∗ =
(𝑥𝑖𝑘− 𝑎𝑖 )
𝑏𝑖
  Equation 2.7 
 
where 𝑥𝑖𝑘 = spectral measurement at the kth wavelength for the ith sample; 𝑚𝑖 = mean of 
the k spectral measurements for sample I; 𝑆𝑖 = standard deviation of the same k 
measurements; 𝑎𝑖 = additive correction factor calculated from regression method; 𝑏𝑖 =
 multiplicative correction factor calculated from regression method. 
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While in the case of SNV, mean and standard deviation of variables intensity 
(wavelengths) of the spectra are used, 𝑎𝑖  and 𝑏𝑖 estimation in MSC is a result of “a linear fit to 
a reference spectrum” [26]. Since SNV does not involve fitting, it has the disadvantage of 
being sensitive to noisy entries [28]. In MSC, problems may arise if the reference spectrum 
(usually the average of a set) is not representative of new data [29]. 
Another likely phenomenon is the baseline offset and in this case, derivatives are usually 
the preferred technique not only because they completely remove baseline variation between 
spectra, but also enhance the variability along them due to differences in their slope (in the 
case of 1st derivative) and subsequent changes, allowing a better resolution for overlapped 
features [26]. This converts a “subtle” signal into a detectable one, allowing that property to be 
accurately identified and quantified. The use of the second derivative enhances the effect of 
the first derivative. 
The use of spectroscopy in this project requires the use of these techniques (especially in 
the case of NIR). Selection of the overtone areas based on the sample properties as well as the 
removal of noisy regions in the spectra should be done before preprocessing. However, further 
spectra selection could be performed after pre-processing is done. After all these steps are 
performed, the latent variable model can then be computed and therefore the latest stage of 
modeling could be achieved. 
 
 Model characterization 
The type of modeling (PCA, PLS, etc.) and consequent choice of the number of 
components that the model integrates (selection made after analysis of the results), are the last 
steps in model building. An industrially applicable model must be tested (validation) after 
being developed (calibration). Different strategies are used to validate the model, as the 
validation samples might come either from the batch used to develop the model, or from a 
different set of samples. According to it, many statistical indicators should be analyzed, 
depending on the type of data set used for both stages: 
 Root Mean Square Error of Calibration (RMSEC) – Measure of the average difference 
between predicted and measured response values at the calibration stage [23];  
𝑅𝑀𝑆𝐸𝐶 =  √∑
(?̂?𝑖− 𝑦𝑖)
2
(𝑁−𝐴−1)
𝑁
𝑖=1    Equation 2.8 
  
 
22 
where  ?̂?𝑖 = y obtained after testing the calibration equation on the calibration data; A = 
number of PLS factors 
 
 Root Mean Square Error Prediction (RMSEP) – Measure of the average difference 
between predicted and measured response values at the validation stage [23];  
𝑅𝑀𝑆𝐸𝑃 =  √∑
(?̂?𝑖− 𝑦𝑖)
2
𝑁𝑝
𝑁
𝑖=1   Equation 2.9 
where N = number of samples in test 
 
 Root Mean Square Error Cross Validation (RMSECV) – Measure of the average 
difference between predicted and measured response values of samples from the calibration 
set that were placed aside; 
𝑅𝑀𝑆𝐸𝐶𝑉 =  √∑
(?̂?𝐶𝑉,𝑖− 𝑦𝑖)
2
𝑁
𝑁
𝑖=1   Equation 2.10 
where ?̂?𝐶𝑉,𝑖 = estimate for 𝑦𝑖 based in the calibration equation without the sample i. 
 
 Hoteling’s distance (T2) – Non-euclidean distance of each observation in relation to the 
average. If an observation is beyond the 95% limit, it indicates that observation is different 
from the others, but it does not necessarily mean that it is not part of the model. 
𝑇2 = (𝑥𝑖 − ?̅?)𝑆𝑥
−1(𝑥𝑖 −  ?̅?)
𝑇   Equation 2.11 
where S-1 = inverse of the variance-covariance matrix of X; 𝑥𝑖 = observation; ?̅? = sample 
mean 
 
 Q – Residuals (Q) - Off plane distance of samples relative to the plane formed. Most of 
the time, samples whose distance is beyond the 95% limit, may represent an outlier of data, 
that is, a sample that is not part of the model and should be ignored for model building / 
validation. However, its interpretation must be carefully made as it might represent an 
unpredictable behavior of the system [27]. 
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𝑆𝑃𝐸 (𝑄) =  ∑ (𝑥𝑖𝑗 − ?̂?𝑖𝑗)
2𝑖
𝑗=1    Equation 2.12 
where 𝑥𝑖𝑗 is an element of X and ?̂?𝑖𝑗 is an element of ?̂? (model predicted) 
 
 R2 – Fit of the equation obtained after data analysis. 
𝑅2 =  
𝑆𝑆 (𝑒𝑥𝑝𝑙𝑎𝑖𝑛𝑒𝑑)
𝑆𝑆 (𝑡𝑜𝑡𝑎𝑙)
  Equation 2.13 
 
If a quantitative prediction is the goal, calibration Y values to be added might be obtained 
by off-line traditional techniques, being the validation set used to test if the new tools are able 
to follow the developed model. In addition to the validation performed in the model, there are 
some cases where Y values obtained by off-line traditional techniques are used to confirm and 
compare the efficacy of the model, or even as a validation set. 
 
2.1.2 Process Analytical Technology tools 
2.1.2.1 Imaging 
Imaging as a PAT tool is a broad concept. In fact, different kinds of techniques are said to 
apply imaging but the basis amongst them are slightly different. In common, they all have the 
capacity to provide information about spatial distribution which is useful when characterizing 
blend homogeneity, for example [30]. However, its use in pharmaceutical industry is mainly 
deterministic, that is, it is applied to control certain predictable factors (tablet presence in the 
blistering process of a pharmaceutical, for example). However, in this project, its stochastic 
applicability will be tested. Due to the randomness of the processes studied (different spatial 
colorations appear in every image), it is necessary to detect and to interpret the features of the 
image to infer other characteristics (for instance, to quantify a component). This feature is 
more technically and accurately demanding and efforts in this area have not always been 
successful in other fields [31]. 
Imaging is usually associated with spectroscopic information (UV-visible, NIR or 
Raman). However, in this project the definition of imaging is used in the “regular” context, 
that is, a RGB camera is used to take pictures in 8 bit format and their analysis is performed 
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with chemometric techniques. The final image of a RGB camera in a 8 bit format is the result 
of assembling the matrices acquired in Red, Blue and Green band, whose values are defined in 
a Grey Scale from 0 (Black) to 255 (White). Therefore, the treatment of data is made in that 
matrix whose size is defined by the number of pixels of width (N), the number of pixels of 
height (J) and three matrices in depth (Red, Blue and Green) (K) (N×J×K). As they represent 
the same area, these three images are highly correlated, which can be seen after PCA 
treatment. To do that, this 3-Dimensional matrix requires a transformation to a 2-Dimensional 
matrix to be processed and analyzed by the data treatment techniques referred above. This 
transformation is possible due to a reorganization of data: when working with images, a 
vertical unfolding is the preferred technique in which the N and J are multiplied, having a final 
matrix size of ((N×J)×K (Figure 2.2 a) and b)). Once this reorganization is done, the image 
context is lost (although it is reversible). 
 
 
 
 
 
 
 
 
Figure 2.2: Reorganization of an image – 3-Dimensional matrix to a 2-Dimensional matrix 
 
One of the major problems in applying imaging as a PAT tool is the difficulty to process 
such an amount of data. In order to reduce computer memory demand and to take advantage of 
the equivalents given by the eigenvalues / eigenvectors properties, reduction of a 3-
Dimensional matrix to a 2-Dimensional 3×3 matrix is necessary to successfully apply imaging 
in real time (Figure 2.2 c)). This allows for an original image comprised of a 3-Dimensional 
matrix to be reduced up to a 3×3 matrix (in case of RGB imaging).  In case of an image set, 
the final 3×3 matrix is the result of the sum of all images. Therefore, once the 3×3 matrix is 
obtained, the loadings vectors of the image (or of an image set) are easily obtained through 
SVD (Figure 2.3 a)). Then, the correspondent score vectors are calculated using the unfolded 
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several parameters, mainly the characteristics of the camera chosen (resolution, capacity to 
acquire high frames per second, adequate optical parts and a light source [37]) and the 
capacity of the computer to process that amount of data. Texture analysis is among the 
features that RGB imaging can also perform usually with the help of a Wavelet algorithm [38] 
but it is complementary with MIA since the information is lost during unfolding [39]. 
Moreover the existence of different heights in the sample turns the image blurry, which makes 
this technique only possible to achieve when a flat area of analysis is obtained and a small 
height between the camera and the sample is obtained, which is expected in a dynamic 
pharmaceutical manufacturing. Other parameters such as the sensor noise, shutter time and 
exposure time influence the quality of the image obtained [37]. The major limitation of RGB 
imaging is the fact that a contrast must exist between the particle intended to be quantified and 
its host, although some techniques exist (hue, saturation, intensity - HSI) to enhance these 
differences [40].   
 
2.1.2.2 Near-Infrared Spectroscopy 
NIR spectroscopy is widely used in industry and has been the most used tool in the PAT 
initiative. Its importance is quite evident since it lead to the release of a specific guideline by 
European Medicines Agency (Europe Regulator) and FDA relative to the subject [41][17]. Its 
specificity, speed of response, wavelength stability, larger sample analysis and the fact of 
being non-destructive turns it into an attractive tool. This technology takes advantage of the 
fact that the combination of fundamental vibrations and overtones, which every chemical bond 
exhibit, are seen at NIR frequencies [42][43]. It ranges from 4000 cm-1 to 12500 cm-1 (800 - 
2500 nm) which is the region where those features can be measured, which involves no 
sample preparation (contrary to what happens if the mid IR region is investigated, for 
instance) [26]. 
Observed spectral features are based in anharmonicity, Fermi resonance and different 
dipole moments. The first one is responsible for the specific bands in this region, as the energy 
of the molecule is not symmetrical due to its intramolecular forces. The second allows a split 
to other frequencies of two or more absorptions bands originally in the same frequency, in a 
polyatomic molecule [42]. No detailed explanation will be provided about this as it is beyond 
the scope of this report. However, reference on the subject is readily available [42]. 
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Functional groups possessing one or more hydrogen atoms are generally seen in this 
region, especially the ones interacting with carbon, nitrogen or oxygen, although other low 
frequency bands such as C=O and C=C (especially when an alkene group is attached) might 
also be present [44]. Figure 2.6 represents the overtones and combinations, as well as the 
wavelengths where they can be observed [45]: 
NIR is used in the analysis of many compounds - liquids, solids or gaseous and to 
characterize physical state as well [43]. Changes in the intensity of peaks in NIR spectra 
represent a different concentration of the compound or a state transition, which allows 
quantitative determination along with the qualitative characterization, which is useful to detect 
phenomena as segregation, for instance. The fact that H2O overtones are present in the NIR 
range makes it a perfect tool to detect moisture in a composition due to his capacity to 
quantify water content. However, in aqueous solutions, its capacity to quantify other 
components is compromised due to high water absorption [43]. NIR complies with the 
characteristics that all PAT tools must have (fast, non-destructive and accurate), making it one 
of the preferred equipment used in this context. It also allows for a large number of molecules 
to be quantified at the same time and its transferability to industrial application is not difficult 
[46]. Its major limitation is its high detection limit, especially when compared to other tools 
(see LIF section below). 
Once the composition of the multivitamin mixture is known, characteristic bands could be 
selected and a close monitoring and spectral selection could be performed. Thus, phenomena 
like segregation could be detected. 
 
Figure 2.6: Overtones and combinations bands in NIR frequency [45] 
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2.1.2.3 Light Induced Fluorescence 
Luminescence is a type of spectroscopy characterized by the emission of light after an 
excited state has been acquired. If the source of excitation proceeds from photons, it is called 
photoluminescence which can be further divided in fluorescence (LIF) or phosphorescence. 
Explanation of luminescence phenomena is based in Jablonski’s work and it is 
represented in Figure 2.7. Exposition of a fluorophore material to a light source in the region 
of UV-visible light leads an electron from a fundamental state (S0) to an excited state (S2 or 
S1) – transition 1. After a vibrational relaxation (transition 2), the electron either emits 
fluorescence (transition 4) or goes to a lower excited state (transition 3). At this stage, after a 
new vibrational relaxation, the electron can emit fluorescence (transition 4), decay without 
emitting radiation (transition 5) or less likely go to a singlet and triple excited states (transition 
6). If this is the case, the electron goes to phosphorescence (transition 7), or goes to the 
external conversion route. This phenomenon is named photobleaching and it is still not yet 
fully understood, although it is known that the presence of anti-oxidants in the mixture reduces 
this effect [47]. 
 
 
Figure 2.7: Luminescence Jablonski diagram [26] 
 
LIF is characterized by its high sensitivity, low detection limit (concentration as low as 
0.01% might be observed) and dynamic range as well as a fast response, high spatial 
resolution and sensing capabilities [26][48]. The use of a wavelength for emission and another 
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When many fluorophores are present in a sample, more sensitive equipment is required to 
overcome the problem of overlapping. 
The LIF equipment used in this project (presented below) has some features that increase 
the possibility to obtain better prediction. It allows the selection of multiple excitation 
wavelengths and acquires the full emission spectrum. However, a single excitation wavelength 
was chosen (280 nm) since it was the wavelength that provided a higher emission for the API 
and a lower emission for the matrix [53] (reason why other constituents such as 
microcrystalline cellulose  did not represent a problem in this study). Contrary to many other 
probes that have a photomultiplier detector, it produces a full emission spectrum. This avoids 
the univariate analysis characteristic of photomultiplier detectors and therefore allows to 
monitor more than one component at a time even if their spectral emissions overlap. This 
feature is especially important, since the powders in this work are constituted of several active 
ingredients, some of them with fluorophore properties. 
Another important aspect is the choice of the emission source. Light-emitting diode 
(LED) arrays and Laser diode (LD) arrays are the best ones, since they do not heat (do not 
change sample characteristics), do not give any background noise, emission signal precision is 
better and provide a good dynamic control [26].  
A fluorescence spectrum is different from a NIR spectrum, which is evident when 
comparing Figure 2.8 and Figure 2.9. With a fluorescence spectrum, a smoother line is 
obtained when comparing to NIR. The presence of many components increases the noise in 
NIR spectra, making model development much harder in this case. Therefore, in LIF spectra, 
chemometric treatment is not as demanding as for NIR spectra, leading to more accurate 
results. 
 
Figure 2.9: Fluorescence of riboflavin in ethanol [54] 
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The ability to detect low concentration components is the most important and 
distinguishable feature in relation to the others technologies present. Since this work will be 
developed in a multivitamin mixture whose composition have substances that emit 
fluorescence and are present in a low concentration, LIF is the perfect tool to monitor these 
components. 
 
However, the benefits of installing PAT tools are not restricted on monitoring a certain 
component. The information they provide increase process understanding and allow model 
calibration design to be more adequate. Therefore, the influence of some parameters (process 
or formulation related) can be more successfully investigated and included in model building. 
The interaction between these two factors and the extension in which they modify the final 
product specifications must be understood to define an accurate control space in which the 
manufacturer can work without compromising final product quality. In this sense, PAT tools 
play a critical role in this development as they allow detection of underlying phenomena. This 
information is then linked with the powder study performed under controlled conditions 
(rheological tests). Therefore, the concepts that guide powder rheology have to be known in 
order to establish this connection. These concepts are discussed in the following section. 
 
2.2 Monitoring the compression stage – research topics 
Compression is the last step in tablet manufacturing, which consists in a mechanical 
transformation of powder. As referred, powder is transferred from the hopper into the feed 
frame, whose constitution encompasses one or more rotating wheels whose paddles that have 
the function of feeding the powder continuously into the dies, where they are finally 
compressed.  In spite of its importance, an extensive research is not reported, although it can 
still be divided in two major groups (Table 2.1). There are some studies focused on the 
influence of different parameters of the press (either operating parameters – feed frame speed, 
die disk speed – or design parameters – paddles number, die dimension, number of wheels in 
the feed frame) in the powder behavior (modification of flow properties, segregation 
phenomenon, wave behavior, etc.), in powder properties and also in the acquisition by the 
tools (distance to probe, etc.). These types of tests are performed by running simulations 
(mainly through Discrete Element Method (DEM) technique) or through the acquisition of 
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experimental data. On the other hand, some studies have focused on in-line monitoring of the 
process itself, either by assessing (usually, quantifying a component) the circulating powder 
with a probe installed in the feed frame or by testing the intact tablets recently formed. In this 
latter strategy, the techniques are usually performed off-line, although two works refer its in-
line applicability [55][56]. Table 2.1 represents all the studies published so far regarding the 
in-line study of the tablet press, when applicable. In the case of tablet analysis, the extensive 
off-line analysis that can be performed is not listed, since it is beyond the scope of this project. 
However, the application of the tools used in this study for that purpose, is highlighted. 
In the next sections, the outcomes of the studies made regarding the influential parameters 
of the press and the role of powder properties (Section 2.2.1) are presented, followed by the 
work that has been done using the probes chosen for this work especially when used in-line for 
component tracking (Sections 2.2.2, 2.2.3 and 2.2.4) 
 
2.2.1 Influence of press parameters and powder properties 
The feed frame is a piece that is very different between presses, regarding its geometry, 
number and direction of rotation of wheels, shape and number of paddles, etc. Since they 
constitute a mixing mechanism, they are able to change the properties of the powder and 
influence die fill weight variability [12][57]. Therefore, they have been the subject of some 
studies that use simulations to predict powder behavior [58]. However, due to different feed 
frame designs, the diversity of operative parameters (different feed frame and dies speed) and 
the differences in powder properties, the conclusions obtained from these studies must be 
contextualized. In fact, all these factors require that in the implementation of a monitoring 
tool, the conditions used when the model was developed must be respected. Therefore, these 
studies demonstrate that a careful approach must be taken when feed frame monitoring is 
used. However, in spite of the great variability of this stage, these studies help to understand 
which conditions can potentiate a good monitoring strategy. 
Many studies demonstrate that higher paddle speed originates a lower weight variability 
in the dies [57][58] since the availability of the powder is higher. However, it also implicates a 
higher shear stress to the powder, which leads to particle breakage [59] and thus, can induce 
some undesirable phenomena such as segregation, especially in formulations with a higher 
tendency to segregate [12][60] (components with important differences of particle size and  
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Scope Tool(s) Conclusion(s) 
Reference 
number 
1. Influence of press parameters and powder properties 
a) Simulation methodology 
Study of segregation inside feed frame DEM 
Occurrence of size segregation on the feed frame and in die filling, 
mainly affected by paddle wheel speed 
[12] 
Study of paddle speed, number and height DEM 
Faster paddle speed, higher number of paddles and lower paddle 
height lead to lower die fill weight variation; 
[58] 
Evaluate the influence of paddle shape, 
rotation direction and speed; Direction of 
powder flow, Residence Time Distribution 
(RTD) and die filling variability; Effect of 
powder cohesion 
DEM 
Flow and RTD varies with paddle shape, rotation direction and 
speed; More weight stable tablets are obtained for higher paddle 
speeds; Cohesive particles present larger weight variability   
[61] 
Study of RTD of particles and relating 
operating and feed frame conditions 
DEM 
Particle size segregation occurs when small particles have faster exit 
speeds; RTD of particles is affected by paddle and dies speed;  
[62] 
b) Experimental data 
Evaluate influence of paddle speed in weight 
variability 
Sieve, 
Pycnometer, 
PFT(1)  
Paddle speed influence tablet weight variability in low flowing 
powders 
[57] 
Study the effect of design and initial powder 
characteristics in flow characteristics    
(Off-line): 
GDR(2), 
LDA(3) 
Feed frame geometry, operating conditions, die system conditions 
and initial particle size distribution (PSD), changes the final PSD. 
Paddle speed increment in small feed frames does not affect PSD. 
[59] 
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Scope Tool(s) Conclusion(s) 
Reference 
number 
1. Influence of press parameters and powder properties 
b) Experimental data (continuation) 
Evaluation of the effect of powder 
properties, die size, rotary disc speed, paddle 
speed on flow pattern, applied shear and die 
filling uniformity 
Digital 
imaging / NIR 
Powder properties, speed and geometry of feed frame and dies affect 
flow pattern inside the feed frame; Shear and RTD are function of 
blend properties and operating conditions; Cohesion and die filling 
variability decreases with paddle speed 
[60] 
Study of the effect of blend composition, 
and feed frame and die parameters on 
powder and tablet properties 
Quantachrome 
Instruments 
Autotap, 
GDR(2) 
For lubricated blends, feed frame parameters had a large impact on 
powder hydrophobicity and powder properties; Shear promotes flow 
but has an effect in tablet hardness and dissolution 
[63] 
Optimise the probe distance and study the 
influence of powder movement 
NIR 
Optimization of distance; Possibility to minimize agitation effect in 
the signal; 
[64] 
Influence of paddle wheel speed, probe 
location and mass throughput rates 
NIR 
Paddle wheel rotational speeds and probes location must be 
optimized for different geometries. 
[65] 
Understand the die filling process; study 
different parameters that can affect model 
prediction 
NIR 
NIR can be used to determine mass changes inside the feed frame; 
paddle wheel speed has significant impact in dynamics; Distance 
between probe and powder has effect on model prediction; 
[66] 
2. Monitoring 
a) Powder 
Evaluate content uniformity of tablets by 
monitoring of the powder 
NIR 
Successful monitoring of powder with an API of 30% w/w and 2 
excipients 
[16] 
Track an API NIR 4% potency component was successfully identified [64] 
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number 
2. Monitoring 
a) Powder (continuation) 
Quantification of a mixture with two APIs NIR 
Good correlation between off-line tablet analysis and powder 
concentration 
[65] 
Monitor the concentration of API (5-15% 
w/w) 
NIR 
In-line models presented more accuracy and less RMSEC than off-
line models due to an influence of paddle speed. 
[66] 
Evaluate the potential to monitor an API in a 
feed frame 
NIR Univariate analysis led to a good correlation coefficient [67] 
b) Tablets 
Quantification of API on tablet surface  LIF Quantitative correlation between tablet surface and off-line analysis [51] 
In-line monitoring of a continuous tablet 
process 
NIR 
Authors were able to develop calibration models with low error for 
in-line tablet monitoring 
[55] 
Applicability of in-line NIR sensor in to 
quantify API and excipients 
NIR Simultaneous quantification of API and excipients was achieved [56] 
Hardness prediction, API determination, 
Uniformity of dosage 
NIR 
PLS models developed off-line were able to predict hardness, API 
(15-30 mg) and evaluate the UDU. 
[68] 
-Content uniformity, hardness, disintegration 
time, friability; 
NIR 
PLS models developed off-line allowed the prediction of the 
parameters in study (API of 200-300mg) 
[69] 
Compare quantitative off-line LIF 
measurements of tablet surface with a 
reference method (UV) 
LIF 
Two different APIs with a range of 1.64-4.75% and up to 20% were 
successfully quantified through analysis of tablet surface 
[70] 
(1)PFT: Pharma Flow tester; (2)GDR: gravitational displacement rheometer (3)LDA: Laser Difraction Analyzer 
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density in its constitution). Similar effects are expected when higher residence time inside the 
feed frame is potentiated (i.e., decreasing die speed [63]). Paddle speed can also affect the 
dynamics of the feed frame [66], as the wave behavior usually seen in this equipment due to 
the paddle, varies. This can also lead to variations of the signal obtained in the installed probe 
[65], since at higher paddle speeds, dilatation of the powder occurs. For non-contact probes, 
this information is important to evaluate the best S/N ratio and to know other characteristics of 
the compression stage that might be occurring (for instance, a different baseline shift might be 
used to determine the mass inside the feed frame [66]). Since in this work the NIR probe 
works as a non-contact probe, this information represents an indication that a preliminary 
study regarding S/N ratio needed to be performed. 
In terms of powder properties, Mendez et al. [63], demonstrated that lubricated powders 
(especially the cohesive) are more susceptible to shear in terms of their flow properties as they 
show a lower dilatation and flow index and a higher hydrophobicity. This might lead to 
“overlubrication” of the powder which decreases its cohesion that have an impact on tablet 
properties (dissolution and hardness). This information enhances the importance of monitoring 
this stage of the manufacturing process (most of the formulations have lubricants in their 
constitution) and the specificity of the model developed for each blend. 
 
2.2.2 Imaging 
Imaging alone is not a common PAT tool for in-line monitoring of pharmaceutical 
processes, although its usefulness and potential are quite evident. The concept is broad, 
although imaging is usually a feature of an equipment that could also perform another type of 
analysis, usually spectroscopic (NIR, Raman), allowing the possibility to characterize the 
sample both spatially and qualitatively. As this project is concerned, the information obtained 
by imaging will be complemented with the data obtained by other tools, but the equipment 
itself is dedicated (a RGB camera will take pictures). Therefore, taking into account the goal 
of this tool in this work, this section is focused on the studies published in which imaging has 
been use as a dedicated equipment with stochastic goals. 
Monitoring of coating process is the pharmaceutical manufacturing step where imaging 
has been most tested and some results are promising, although no reports were found 
illustrating its use as an in-line tool, which highlights the novelty of this project. A review 
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from Knop and Kleinebudde [71] referred the possibility to use imaging while working with 
pellets, evaluating their difference before and after coating, if a narrow size distribution, a 
uniform coating and a large number of measured particles are obtained. One of the most 
important experiments was performed by Kennedy and Nierbergall [72]. They used digital 
imaging in batch samples and through standard deviation and mean of their optical densities 
calculation, they were able to monitor the uniformity and quantify the thickness of the 
samples, despite the few numbers obtained (around 200). Also at-line, Kucheryavski et al. [73] 
demonstrated a strong relation between image features and pellets growth, comparing the pixel 
area occupied by pellets during the process, after having removed some samples throughout 
the coating stage and inserted them in a 5 cm box for picture acquisition. The use of Angle 
Measure Technique (a chemometric method) showed better robustness than wavelet 
transformation. Mozina et al. [74] also dynamically demonstrated the advantages of this tool, 
using a monochromatic camera and developing and validating a model that was capable to 
detect agglomeration and coating thickness, after separation of the pellets according to their 
shape and size (so the measurement of the coating thickness was not affected by 
agglomeration phenomena) and calibration of pixel size with bearing balls. Applying image 
analysis to optical microscopy to monitor the coating of the pellets based in the mean 
difference of projected area of coated and uncoated pellets, was a study performed by Larsen 
et al. [75] whose conclusions proved the robustness and the advantage of this method due to a 
lower need of sampling (only 1000 pellets). Use of imaging to assess the cosmetic attribute of 
coating was reported by García-Muñoz and Gierer [76] using off-line images to determine the 
coating uniformity end-point. They also inserted an on-line camera inside the pan coater 
(being this case one of the rare examples where on-line imaging was applied in a 
pharmaceutical process) and by using PCA adaptive modelling approach were able to identify 
the time where color of coating stopped changing. 
Imaging has also been studied in the blending step, although fewer studies are reported 
and none of them were performed with an RGB camera. Despite this, Whightman et al. [77] 
were able to quantify the components present in the mixture, after adding a solidifying agent 
to the mixture and analyzing it after the mixture was sliced. They used parameters as average 
coloring to quantify the components. Also Realpe and Velázquez [78] proved imaging can be 
used for quantification of mixtures and exhibit the same precision as NIR, having used mean 
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gray values of several mixtures to calibrate the model, which is an indication of imaging 
applicability in this project. Another work by Daumann et al. [79] referred imaging as a 
suitable method to monitor efficient mixing as they put a color tracer in a mixture, isolated it 
through image reprocessing and transformed the analysis in a colored binary code to monitor 
the efficiency of blending throughout time through the analysis of empirical variance of the 
trace concentration (color). The use of imaging to evaluate certain phenomena such as their 
tendency to the blends to segregate has also been reported, taking advantage of its feature to 
determine the size of the particles [80]. 
Although none of the works described above has used this tool in-line, there have studies 
in other industries that have successfully applied it in this condition for the qualitative and 
quantitative characterization of a process. One of the most important was performed by Yu 
and MacGregor [35] in which the performance of a boiler system was evaluated in-line by a 
RGB camera through the acquisition of pictures of flames generated by combustion. Based on 
the color difference of the flames, the authors were able to predict, among other things, the 
concentration of components present in the combustion reaction or originated by it, which is 
what it is intended in this work. Also in the food industry, the implementation of an in-line 
RGB camera in the production of snack foods was used to predict its coating concentration 
and distribution [81][82]. The use of an RGB camera was used in another study that was able 
to monitor in-line the flotation process, after a selected region comprising the features of 
interest was chosen in the score plot and ulterior wavelet texture analysis was applied do 
distinguish between two features of interest [83]. The change in the score plot was used to 
follow the manufacturing process. The chemical industry has also successfully applied 
imaging as on-line tool, especially in crystallization processes to monitor the shape and size of 
crystals [84]. 
 
2.2.3 Near-Infrared Spectroscopy 
Near-Infrared is one of the most used equipment in PAT applications as it perfectly 
complies with the characteristics demanded for these types of tools. Along with the water 
content referred above, there are many others parameters that can be measured with NIR 
whether in, on, at or off-line. A review article by Luypaert et al. [85] discussed all applications 
and studies that had been done with this technology until then, highlighting its usefulness in 
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raw material identification, particle size measurement, tablet hardness measurement and also 
in components quantification, reason why it is commonly used to monitor drug potency. Also 
for that reason, it is a suitable tool for segregation detection [86]. Moreover, properties like 
powder particle size, pH, moisture content, flow related properties, flowability and angle of 
repose have also been successfully modeled and could be predicted by this tool [87]. NIR has 
also demonstrated its ability to detect process changes and interferences as well as to study the 
kinetic of a mixture [88][89][90]. 
Due to the scope of this thesis, the in-line application represents the major point of 
interest. In fact, unlike imaging whose applications have been restricted to the manufacturing 
stages of blending and coating, studies using in-line NIR spectroscopy have been explored in a 
much larger extension. Along with these two manufacturing steps [91][92], there are many 
studies referring to its utility in granulation [93], drying [94], compression [65] and freeze-
drying [95]. In case of (wet) granulation, drying and freeze-drying, NIR spectroscopy utility is 
mainly justified by its capability to monitor water content. In the coating stage, as the core is 
coated, higher reflectance is observed, which leads to a change in spectra and enables the 
monitoring of coating end point as well as determination of coating thickness [96]. In blending 
and compression stages, NIR spectroscopy is a powerful method to determine homogeneity 
(which identifies blending end point) and for drug quantification (which identifies potential 
segregation phenomena), which is the feature of interest in this project. Its capacity to 
determine particle size is also important to understand the behavior of powder and recently, its 
use as a tool to assess in real time the powder density has been reported [97], parameter that is 
critical to maintain uniformity of the blend. As a first choice PAT, its applicability has also 
been applied in several continuous manufacturing stages [98]. 
Taken into account the focus of this project in the monitoring of the compression stage, it 
is pertinent to highlight the most significant reports that were published regarding this 
manufacturing stage and using NIR. As mentioned above, two different strategies to monitor 
the compression stage can be distinguished: a) Monitoring of the tablet and b) Monitoring the 
powder in the feed frame. In the first case, many off-line studies report the success in the 
quantification of the components and other tablet parameters by acquiring data from intact 
tablets [68][69]. On the other hand, an in-line strategy to use intact tablets to monitor the 
compression stage was suggested by Karande et al. [56]. Despite having installed the probe in 
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the press machine, their analysis was performed in the product final form (tablet) and not in 
the powder. They were able to develop a model to quantify both the API and the excipients 
and proved it could detect powder phenomena such as segregation, since in one of the batches 
a difference in concentration between the components was observed, phenomenon which the 
authors attributed to the hopper geometry and to the difference in particle size and density of 
the components. Another in-line analysis of tablet was done by Järvinen et al. [55], as part of a 
continuous tabletting system. In this work, acetaminophen tablets with a concentration of 20-
30% (w/w) were successfully predicted based in a VisioNIR system placed at the exit of the 
dies (Figure 2.10). Despite of these studies and as mentioned in a recent review made by 
Laske  
 
Figure 2.10: VisioNIR sensor to analyze tablets [55] 
 
et al. [99], analysis of the tablet by spectroscopic methods present in general a lower S/N ratio 
when compared with powder analysis due to the higher specular reflection observed in tablets 
along with a more surface analysis (depth of penetration in tablets is also lower). Therefore, 
monitoring the circulating powder in the feed frame seems to present a better strategy to 
control the compression stage at least by the use of spectroscopic methods, as suggested in this 
work. However, there are not many reports about the use of NIR in the feed frame. A work by 
Liu and Blackwood [64] was one of the first that placed an in-line NIR probe above a window 
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in the feed frame of a rotary press machine. They were able to detect a variation in 
concentration of 70% in a 4% (w/w) drug load. Ward et al. [65], used a similar setup (Figure 
2.11) and placed a powder constituted by placebo and then a layer of API (in the first test with 
a concentration of 3.5% (w/w) and in the second with a concentration of 30 % (w/w)) in the 
hopper and were able to detect concentration changes in the feed frame, having also 
established a good relation between potency detection and off-line results obtained by 
traditional techniques. More recently, a work by Wahl et al. [16], demonstrated the ability of 
NIR to monitor in-line a composition of 30% API with 2 excipients whose model was 
developed off-line. In this study, the authors were also  
 
Figure 2.11: NIR probe installed in the feed frame [65] 
 
able to detect segregation by the end of their run, which were attributed to the discharge from 
the hopper. Another study by Šašić et al. [67], pointed the potential of a NIR mounted in a 
feed frame to monitor the API, after a univariate profile, selected at the typical band of 
absorption of the API, was developed and correlated with off-line analysis. Therefore, all these 
studies indicate the utility of NIR to quantify components in the feed frame in a different range 
of concentrations. 
Many of the studies concluded about some technical parameters that are critical to 
implement this technique. Liu and Blackwood [64] studied the influence of probe position in 
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spectra acquisition and concluded that the dynamic measurement of spectra could be 
performed if the probe was in an accurate position and adequate data pre-processing was done. 
The same conclusion was observed by Ward et al. [65] whose work also investigated the 
influence of mass flow rate inside the feed frame and the paddle speed (varied between 10 and 
40 rpm). They observed a close relation with off-line measurements when mass flow rate was 
changed, but in the case of paddle speed, there was a slight bias in the NIR measurements. 
Another important technical study was performed in 2007 by Li et al. [100]. The authors 
studied the influence of beam size of the in-line NIR sensor in the blending stage and 
suggested that this factor is important when building a model to quantify components. In other 
study, Mateo-Ortiz et al. studied the influence of many other parameters that could be obtained 
through NIR [66], as well as factors that must be considered when this tool is applied in the 
monitoring of the feed frame. They concluded that the baseline of the NIR spectrum could be 
used to assess the mass inside the feed frame. The baseline was also shown to be affected by 
the paddle speed due to the changes in powder density it originated, which put the powder 
closer to the probe. They also demonstrated that the NIR prediction is strongly affected by 
paddle speed which confirmed the specificity of each of the models developed for a certain 
condition. However, in this project, installation of a trigger in the set-up was done to minimize 
the noise by selecting a specific area of acquisition.  
 
2.2.4 Light Induced Fluorescence 
As imaging, LIF applications in pharmaceutical industry are rare. Its application is mainly 
used in monitoring powder blending (whether detecting the end point or homogeneity) through 
drug quantification and in the quantification of tablets. 
In the case of blending, all studies reported in literature showed a good capability to detect 
homogeneity and signal the end point, despite some limitations of the method due to the API 
concentration. In one of the initial studies performed by this tool using an on-line strategy, Lai 
et al. [101] proved a linear relation could be obtained from a concentration as low as 0.1% to 
1% API (w/w) of Triamterene, demonstrating the potential of this tool to monitor high potency 
drugs. However, a nonlinear behavior was observed for higher API concentration, which was 
believed to be due to the saturation of the photomultiplier tube. In a later study, the same 
author [52] was able to monitor the concentration of Triamterene as low as 0.02 % w/w in the 
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powder. In this work, the potential of this tool to detect segregation was also shown, since 
segregation was statistically demonstrated, after analyzing the obtained LIF signal in 
theoretically homogenous blends. This feature is of the upmost importance when monitoring 
the feed frame and reveals the importance of the installation of this tool in this piece of 
equipment. 
A study by Karumanchi [49] demonstrated the applicability of LIF to monitor 
qualitatively the blending stage and is well correlated with conventional HPLC techniques. 
More recently, Guay et al. [53] installed a LIF probe in a lab-scale V-blender and were able to 
develop an accurate model to follow the API (concentration between 1.44 and 4.19%  w/t) in a 
study that proved the applicability of LIF as a PAT tool. This work validated the option of 
selecting LIF in this work, as it was able to track in-line low dosage components. 
In the case of tablets, two main studies must be highlighted. In the first case, Lai et al. 
[51] were able to establish a linear correlation for concentrations of Triamterene tablets 
between 1.64% and 4.75% w/w just by analyzing their surface and monitored in a high surface 
rate – 3000 tablets/min. In another study, Domike et al. [70] using the same concept, was able 
to establish a correlation for tablets containing caffeine in a concentration up to 20% w/w. 
Since it is a relatively new technique, these studies also present a lot of technical 
information that must be taken into consideration in the implementation of this tool. For 
instance, the dynamic capability of this method has been proved and it was shown that both 
blending homogeneity and drug content can be adequately predicted using this kind of setup, 
even if a single emission wavelength is used (in this case, mixtures components did not 
interfere between them) [51][52]. Also the penetration depth of LIF was investigated. Lai et al. 
[51] found that in tablets prepared by 3D Printing procedure, 30% of the signal of LIF was 
detected in a 1 mm depth, leading to the conclusion that if this tool can penetrate this much in 
a loose powder, it is expected that the penetration will be much lower when working with 
denser powders. Since in this project a free flowing powder was used, this depth was 
considered for calculating the mass analyzed by each observation – Annexes A1. Light 
penetration inside the sample will depend on the characteristics of the powder being studied, 
mainly the particle size and its density, as well as the selected wavelength. Shah et al. [102] 
reported a study where the density of the powder was correlated with the response from the 
LIF. They observe that a linear response from the LIF was obtained when the density 
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increased up to 4% w/w, but from this value on, a negative trend was observed, confirming the 
influence of the density of the powder on the results obtained by this tool. In his study, Guay 
et al. [53], concluded that changes in moisture, pressure (hydrostatic forces, for instance), 
particle size and especially the presence of colored components, affect the LIF signal and must 
be controlled in routine, which is a relevant information for this work since many other 
colored components are present in the studied blend. 
Some improvements are also reported in the equipment. Recently, Dickens et al. [103] 
published a work where a LED-array fluorescence sensor was developed to investigate the 
improvement of the sensitivity of the equipment. They used a dynamic emission that led to a 
broader detection capability which allowed them to detect concentrations of the component in 
study (Tryptophan) as low as 0,001% (w/w). 
All the studies referred above indicate the potential of these tools to be used in the 
proposed conditions. However, the development of monitoring tools is not straightforward and 
goes through different stages. In the next three chapters, the papers that arose from this work 
are presented. They chronologically describe the logical and typical sequence of studies made 
when the goal is to implement a PAT tool in a process. Therefore, in chapter 3 a qualitative 
analysis of the potential of the tools is assessed and a technical evaluation of the set-up is 
evaluated. After its successful completion, a quantitative evaluation was performed in the 
press (chapter 4) in which the benefits of simultaneous use of tools is determined, as well as an 
evaluation of blend kinetics. Finally, in chapter 5, the evaluation of the robustness of the three 
PAT tools is explored. 
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NOTE 
 
The following chapter is based on a paper entitled “Monitoring the concentration of 
flowing pharmaceutical powders in a tablet feed frame” and was published in “Pharmaceutical 
Development and Technology”. 
It has been included here as part of Pedro Filipe Marchão Palmeiro Durão’s work. Due to 
a misunderstanding with the journal, the first author is indicated as Ryan Gosselin, while it 
should have been Pedro Filipe Marchão Palmeiro Durão. Demands to the journal to make 
corrections upon reception of proof copies have not been successful. 
 Permission to include this chapter in this thesis has been requested to the Faculty and has 
received special approval by the vice dean of research. 
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Summary 
Content: The first step in the implementation of a PAT tool is to evaluate its potential to 
monitor the selected CQA. In this paper, it is intended to qualitatively evaluate the potential of 
the selected tools (NIR, RGB camera and LIF) to detect differences in concentration of certain 
components in the proposed set-up. The components to monitor were selected according to 
their characteristics and of the tools in place. Five different blends (with six components) were 
used and the concentration of three components varied between them. The trial was performed 
by simulating the conditions usually found on a press. 
 
Results: Through the use of MVDA, the variation of the first PC - calculated after PCA 
analysis - was plotted throughout the experiment for each of the probes. Assuming the 
variation of the score values had a relation with the concentration of the components, it was 
demonstrated that all tools were able to detect a difference in the concentration at least in one 
point of the experiment. In addition, it was possible to correlate the variation of the score 
values with the concentration of the components, allowing to determine which components 
could be monitored by each of the tools. 
 
Contributions to the thesis: This paper allowed to confirm the potential of RGB imaging and 
LIF spectroscopy to be used in-line in the monitoring of components (the applicability of NIR 
had already been evaluated in other studies) in the proposed set-up. It also confirmed the 
potential of LIF to be used in the quantitative evaluation of low dosage components. 
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Abstract 
The use of process analytical technology (PAT) tools is increasing steadily in the 
pharmaceutical industry. Such tools are now located throughout the process. When producing 
tablets, the tableting step itself may be the ideal moment to assess final product composition. 
Being the last unit operation in tablet production where the elements are still free flowing, it is 
relatively straightforward to ascertain the composition of the blend in real time. However, a 
single probe cannot be expected to monitor the composition of every component of a 
multicomponent blend. In this study, 3 PAT tools (light-induced fluorescence spectroscopy, 
near infrared spectroscopy and color (RGB) imaging) simultaneously checked the composition 
of powder blends flowing through the feeding unit (feed frame) of a tablet press. The results 
demonstrate the potential of these tools in monitoring changes in concentration of a 
multicomponent mixture in real time, providing users with means to both scrutinize the 
process and better understand phenomena occurring inside the feed frame. 
 
Keywords: Tablet Press; PAT; Imaging; Near-infrared; Fluorescence 
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Résumé français: 
L’utilisation des technologies d’analyse de procédés (Process Analytical Technology, 
PAT) est en augmentation dans l’industrie pharmaceutique. Ces technologies sont maintenant 
implantées directement dans les procédés de fabrication. Lors de la production de comprimés, 
l’étape de compression est idéale pour évaluer la composition finale du comprimé. Cette étape 
est la dernière durant laquelle les différents éléments composant le mélange sont libres, il est 
donc relativement aisé de vérifier la composition du mélange en temps réel. Cependant, il 
n’est pas réaliste d’espérer qu’une unique sonde puisse déterminer la concentration de tous les 
composés d’un mélange complexe. Lors de cette étude, trois technologies différentes 
(spectroscopie de fluorescence induite par la lumière, proche infra-rouge et imagerie 
couleur (RGB)) ont été utilisées simultanément pour vérifier la composition du mélange 
s’écoulant de l’unité de remplissage (trémie d’alimentation) de la presse à comprimer. Les 
résultats de cette étude démontrent le potentiel de ces technologies pour suivre en temps réel 
les changements dans la composition du mélange, cela permettant aux utilisateurs de suivre 
précisément le procédé ainsi que d’avoir une meilleure compréhension des phénomènes se 
produisant dans le bol d’alimentation. 
 
Mots-clés: Presse à comprimé; PAT; Imagerie; Proche Infra-rouge; Fluorescence 
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3.1 Introduction 
Since the 2004 publication of “Guidance for Industry PAT – A Framework for Innovative 
Pharmaceutical Development, Manufacturing, and Quality Assurance” [1], the use of PAT 
tools by the pharmaceutical industry has been the subject of considerable scientific work. 
Although PAT tools (e.g. NIR spectroscopy) are now commonly employed for off-line 
measurements, their true potential may lie in their application to in-line or on-line 
measurements [69]. The information provided by these tools makes it possible to monitor the 
process in real time, leading to better process understanding, improved quality of the final 
product and the reduced need for post-production destructive sample testing. 
 
3.1.1 Tableting 
Tableting is the last stage in the manufacturing chain in which the product is still in free-
flowing powder form. As such, powder monitoring at this step makes is possible to ensure that 
the product meets quality specifications. Late-stage monitoring can quantitatively determine 
the composition of the mixture being compressed, assess mixture homogeneity and detect 
undesirable phenomena, such as agglomeration and segregation. The latter could occur 
anywhere inside the process, from the intermediate bulk container, to the hopper or even 
inside the feeding unit (i.e. feed frame) itself. Gauging powder quality inside the feed frame 
may reduce the need for off-line tablet analysis which is destructive, time-consuming and 
costly. Therefore, PAT tools in this step of the manufacturing process are fundamental to 
enable real-time release by reducing the necessity of further quantitative API testing. 
The present work evaluates the potential of combining three tools, NIRS, LIF and color 
RGB imaging, to monitor variations in concentration of a dry particulate system, inside the 
feed frame of an industrial tableting press. 
 
3.1.2 PAT tools 
Different technologies have been applied as PAT tools: for example, spectroscopy such as 
NIRS and Raman are among the probes most commonly deployed for this purpose [104] 
because of their numerous advantages (e.g. high acquisition rates, non-destructiveness, non-
invasiveness). Color imaging has emerged as one of the most promising tools for PAT 
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purposes [76], although its usefulness has been reported in few studies from the 
pharmaceutical industry. LIFS, a technology which takes advantage of the fluorescent 
properties of components, is gaining acceptance in the field, especially when low-dose 
components are present [53]. All these tools generate large amounts of data, which usually 
require multivariate analysis [21]. 
Several studies, reported in the literature involving process monitoring via PAT tools, 
have focused on solid particles, since they represent the bulk of pharmaceutical production 
[105][106]. Different stages in the manufacturing process, such as blending and granulation, 
have been investigated in PAT applications with the help of these tools [104]. However, 
despite the importance of the tableting step in final product quality, not much work has been 
done on the utility of PAT tools to monitor powder flows entering the tableting stage. Reports 
in the literature demonstrate the possibility of monitoring the composition of powders present 
in the feed frame of a press machine and detecting segregation phenomena with NIRS 
technology. Ward et al. [9], used a step change technique to demonstrate the suitability of two 
NIR probes to detect differences in the concentration of the mixtures (API contents ranging 
from 3,5% to 30%) and linked their potency to off-line measurements of the tablets. They also 
studied the influence that certain parameters (throughput rate and rotation speed of the feed 
frame speed) had in the signal output of the tool. Also, work by Wahl et al. [16] monitored the 
composition of the API (30%) and of two excipients (65% w/w in total) using an in-line NIR 
probe, after the development of an off-line PLS model. Along with the detection of drug 
concentration, they also proved the utility of this technique to detect segregation in the 
process, which was later confirmed by the off-line tablet analysis. 
 
3.2 Materials and methods 
3.2.1 Set-up 
The tableting feed frame is part of a Manesty Novapress 37-station rotary tablet press 
(Figure 3.1). It consists of two intermeshing wheels (each with 10 paddles). Powder enters the 
feed frame in the inlet chute directly onto the counter clock-wise rotating wheel (right), then 
goes on to the clock-wise rotating wheel (left), where it is scanned by probes before being 
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Table 3.1: Experimental design 
 
Vitamin I 
(w/w %) 
Vitamin 
II (w/w 
%) 
Vitamin 
III (w/w 
%) 
Calcium carbonate, 
vitamin E and 
magnesium stearate 
mixture 
(w/w %) 
Monitoring tool 
Mixture 1 5 0 0 95 Transition 1 to 2: 
RGB, LIFS 
Mixture 2 5 4 2 89 
Transition 2 to 3: 
NIRS 
Mixture 3 11 4 2 83 
Transition 3 to 4: 
RGB, LIFS 
Mixture 4 11 4 0 85 
Transition 4 to 5: 
NIRS, RGB, 
LIFS Mixture 5 8 2 1 89 
 
Thus, vitamin I is known to be NIRS-responsive, the dark brown color of vitamin II can 
be tracked by RGB, and vitamin III’s fluorescence makes it a suitable candidate for 
monitoring by LIFS. It is noteworthy that vitamin III’s yellow tint may also be useful in RGB 
analysis as it is distinguishable from the dark brown color of vitamin II. 
The mixtures were processed in a 6.5 quart V-Blender (filled to 50%) before being 
manually added to the press hopper. When the hopper ran out of powder, the feed frame was 
stopped and the next mixture was added for the following run. The feed frame was not cleaned 
between runs in order to monitor composition transitions. As such, changes in composition of 
the inlet stream can be likened to successive step changes in composition. As mentioned, each 
probe measures the blend once every rotation of the feed frame paddle, which translates into 
approximately 50 acquisitions for each mixture. 
 
3.2.3 Software 
The trigger and lighting systems were controlled by Labview (National Instruments, 
Austin, TX). LIFS data were collected by NovaPac (Prozess Technologie, St. Louis, MO). 
Data analysis was undertaken with in-house Matlab (MathWorks) algorithms. 
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3.2.4 Data treatment and presentation 
The five mixtures (Table 3.1) were analyzed via LIF, NIR and RGB. An overview of the 
original data is presented in Figure 3.3. 
 
 
 
Figure 3.3: Original acquisitions of the five mixtures (a) NIR spectra, (b) RGB images and (c) LIF 
spectra 
 
For NIRS, the data were pretreated with standard normal variate before being centered 
and scaled to unit variance (UnV). For RGB imaging, the original 5 MP images were cropped 
to the region of interest. The final images (900 x 400 pixels) were first re-shaped into a 2-D 
matrix (Figure 3.4), centered and analyzed via MIA [34]. 
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Two-component PCA represents 85.7% of data variance (t1: 65.3%, t2: 20.4%). It is well-
established that the presence of color variations may impact the performance of this tool [53]. 
Here, the dark brown color of vitamin II could influence the signal. Nevertheless, Figure 3.6 
a), which represents variation of t1, illustrates the response of the tool as it follows vitamin III 
concentration throughout the experiment (mixtures 1 to 2, 3 to 4 and 4 to 5). Figure 3.6 b) 
represents the PCA of the two first components, in which the process clearly follows a counter 
clock-wise trajectory in the score plot. These results confirm the capability of this probe to 
distinguish low-dose blends, in much the same manner as was discussed for NIRS. 
 
3.3.3 RGB 
Two-component PCA of the RGB images represents 92.3% of data variance (t1: 70.1%, t2: 
22.2%). Figure 3.7 a) illustrates variations of both PCA t1 throughout the experiments. As 
expected when comparing the raw images (Figure 3.3 b)) with the t1 variation, a clear transition 
is seen when mixture 2 is added, which corresponds to the presence of vitamins II and III 
(Figure 3.7 a)). Unlike the NIRS signal, steady state is reached with the RGB signal around 
500 s in mixture 2. 
Transition between mixtures 3 and 4, which differ by only 2 w/w % of vitamin III but 
cause significant changes in t1 values, clearly illustrate the sensitivity of the method. With 
steady state time points occurring during the processing of mixture 1 (1 to 282 s), the noise on 
t1 appears to be approximately 750 (dimensionless). Thus, transition 3 to 4 had a S/N ratio of 
8.3, placing it between typical values for the limit of detection of 3 and the limit of 
quantification of 10. The final transition, due to the addition of mixture 5, proves once more 
the sensitivity of this tool for color components, as this change corresponds to decreased 
vitamin II and III concentrations.  
These results reveal that the tool is able to detect variations in vitamin III concentrations 
similar to those present in multivitamin compounds. As for vitamin II, the results do not make 
it possible to determine whether signal variation was due to the combination of either 
components or whether it was simply due to vitamin III. 
Figure 3.7 b) illustrates the t1-t2 score plot. Unlike the observations made for NIRS and 
LIFS, the RGB observations appear to remain roughly in the same location over time 
(following an arc-shaped pattern). This appears to indicate that color imaging is far less 
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Table 3.2: First-order k values and 95% CI for every transition 
 NIRS RGB LIFS 
Mixture 1 
- 0.175 ± 0.019 0.069 ± 0.005 
Mixture 2 
0.024 ± 0.001 
- - 
Mixture 3 
0.052 ± 0.006 0.038 ± 0.005 
Mixture 4 
0.070 ± 0.020 0.107 ± 0.014 0.053 ± 0.006 
Mixture 5 
 
The fact that k values can differ for a single probe may be related to varying powder 
compositions throughout the study. In this sense, if varying powder properties influence the 
throughput rate of the feed frame, they should impact the dynamics perceived by all three 
probes. However, these tools acquired different portions of powder flow within the feed frame 
(troughs: NIRS and RGB; crests: LIFS). While these areas are linked, there is no reason why 
they would exhibit exactly the same dynamics for all components of the mixture. Since NIRS 
only tracked a single component which was not detectable by the other probes, it was not 
possible to directly compare the k values. However, RGB and LIFS shared three transitions 
during the experiments. As indicated in Table 3.2, the dynamics measured via RGB and LIFS 
appear to be correlated. The k values calculated in the first transition (mixture 1 to mixture 2) 
decrease in the transition from mixture 3 to mixture 4 and increase once again in the transition 
from mixture 4 to mixture 5. This correlation between the dynamics, measured via RGB and 
LIFS clearly supports the hypothesis that variations in calculated k values may be linked to 
changes in overall rheology of the blend and may improve process understanding. 
 
3.4 Conclusion 
This work was intended to determine the potential of NIRS, LIFS and RGB in monitoring 
the composition of flowing powder in the feed frame of a pharmaceutical tableting press. 
Using a six-component mixture, changes in the concentration of three ingredients, all present 
in pharmaceutically relevant concentrations, were detected by PAT tools.  
The results indicate that these probes are capable of monitoring the composition of 
flowing powders in real time. While three probes were used in this study, the goal here was 
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not necessarily to propose a set-up in which all of them would always be employed 
simultaneously. Rather, the goal was to have a versatile system in which the right probe, or 
probes, would be operated as needed. Here, all three probes successfully monitored the 
intended products (vitamins I, II and III). This is important as it limits the correlation between 
probes and leads to better process understanding.  
Our work reports the first application of both RGB imaging and LIFS to monitor powder 
flow in real time inside a feed frame. With such data, it was established that the kinetics of 
each transition step was well-represented by a first-order model. Although we do not yet have 
a comprehensive understanding of the underlying phenomena occurring inside the feed frame, 
it is logical to attribute our observations to different rheological behaviors of the powder 
mixtures. These probes, alone or combined, have proven to be suitable in studying feed frame 
dynamics and, consequently, detecting undesirable phenomena, such as segregation. 
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Summary 
Content: After the assessment described in the previous chapter regarding the potential of 
these tools to be used in-line in the monitoring of the components in the feed frame, the next 
step was to evaluate the accuracy of quantitative models. Therefore, in this chapter, PLS 
models are developed for five components present in a multivitamin blend. This blend was 
selected to be studied due to its complex formulation, which would test the accuracy of these 
tools for the targeted components. 
The benefits of combining data from several tools to monitor a component were also 
evaluated as well as the modification of rheological properties of the blend was assessed 
through evaluation of its kinetics, obtained after changing the concentration of some 
components. 
 
Results: Four of the five vitamins in this study could be modeled with accuracy by at least one 
of the tools, including the monitoring of a low dosage component (by LIF). Combining data 
from several tools proved to be a good solution to increase accuracy prediction of a 
component. The contribution of each tool for that prediction (important to select which tool to 
use in case it is not possible to use all the recommended tools) can also be obtained through 
chemometrics. It was also concluded that blend kinetics was not affected by the difference of 
concentration of a component between blends. 
 
Contributions to the thesis: The tools in study (NIR, RGB camera and LIF) demonstrated to be 
capable to be used as quantitative instruments in the in-line monitoring of a component in a 
feed frame, even if a complex blend is in place. Moreover, in case of LIF, a low dosage 
component was able to be tracked with accuracy. It was also demonstrated that the strategy of 
combining data from different tools promotes better accuracy of the models developed and 
thus, monitoring of a CQA by more than one tool is encouraged. 
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Abstract 
As PAT implementation grows in the pharmaceutical industry, more studies are being 
performed to evaluate its suitability in new applications and processes within the 
manufacturing chain. As the last step in tablet production, the compression stage represents a 
critical phase that ensures product quality. In-line control put in place at this stage has the 
potential to detect powder blends that are out of specification limits and, thus, help to improve 
product quality. 
The objectives of the present project are to quantify the composition of a commercial 31-
component multivitamin powder blend in real time on an industrial feed frame, using 3 
different PAT tools: LIF, NIR and RGB color imaging. 
To do so, the concentrations of 5 components (beta-carotene, riboflavin, ferrous fumarate, 
ginseng and ascorbic acid) were alternately changed and monitored with one or many probes. 
Transition periods between batches served to quantify different powder flow dynamics with 
sequential composition step changes.  
The results showed that 4 out of 5 components, each present in commercially-relevant 
concentrations, could be monitored by one or more tools. Flow dynamics were measured and 
found to vary significantly in different powder blends.  
 
Keywords: Pharmaceutical; Multivitamin; Tablet Press; Monitoring; PAT; Kinetics 
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Résumé français: 
L’implantation de PAT dans l’industrie pharmaceutique est en pleine croissance. De ce 
fait de plus en plus d’études sont réalisées afin d’évaluer leur pertinence dans de nouvelles 
applications et dans de nouveaux procédés sur les chaînes de fabrication. Etant la dernière 
étape dans la fabrication de comprimés, la compression représente une étape critique dans la 
qualité du produit. Les contrôles en ligne mis en place lors de cette étape permettent de 
détecter des mélanges dont la composition est hors des limites de spécification et ainsi 
d’améliorer la qualité du produit. 
L’objectif de cette étude est de quantifier la composition d’un mélange multi-vitaminique 
commercial contenant 31 éléments, en temps réel, dans une trémie d’alimentation de type 
industriel en utilisant trois technologies analytiques de procédé différentes : LIF, NIR and 
imagerie couleur (RGB). 
Dans ce but, les concentrations de cinq éléments (béta-carotène, riboflavine, fumarate 
ferreux, ginseng et acide ascorbique) ont été alternativement modifiés et contrôlés à l’aide 
d’une ou de plusieurs sondes. Les périodes de transitions entre chacun des lots ont permis de 
quantifier les différentes dynamiques d’écoulement des poudres en changeant de manière 
séquentielle les concentrations entre les éléments.  
Les résultats montrent que 4 des 5 composés, tous présents à des concentrations 
représentatives d’un produit commercial peuvent être mesurées par une ou plusieurs 
technologies. Les dynamiques d’écoulement ont été mesurées et il a été mis en évidence que 
ces derniers variés de façons significatives en fonction de la composition du mélange.  
 
Mots-clés: Pharmaceutique Multi-vitamine; Presse à comprimé; Suivi en ligne; PAT, 
Cinétique 
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4.1 Introduction 
Pharmaceutical science and engineering are strongly regulated fields because of their 
potential impacts on human health. Numerous requirements are in place to ensure that only 
high-quality products are manufactured. Historically, before being released on the market, 
final product testing happens through validated and frequently-destructive techniques (e.g., 
dosage uniformity, dissolution). If these analyses fail to meet prevailing norms, the entire 
production batch is typically rejected (only exceptionally can it be reprocessed), which causes 
significant delays and financial losses [107]. However, the paradigm has been changing in 
recent years. 
After the publication of Q8 [2], Q9 [3] and Q10 [4] guidelines, along with 2004 FDA 
PAT guidance [1], the focus has remained on monitoring, understanding and controlling 
processes, with intermediate and final product testing as complementary methods, to ensure 
product quality (especially when a PAT approach is implemented). This is done by controlling 
critical quality attributes of the process, preferably in real time, which could avoid subsequent 
out-of-specification features. Problems of sample representativeness and destruction are also 
reduced through PAT. These advantages have led to the development of PAT adapted for 
different steps of the manufacturing chain, such as blending, granulation, drying, compression 
and coating [104]. Although their usage throughout the manufacturing process is relevant, 
certain critical steps (e.g., drying and blending end-points as well as tableting) may yield more 
expedient knowledge of final product quality. 
Selection of the most suitable PAT tools is, therefore, of the utmost importance. It 
depends on processing line characteristics (e.g., line speed, geometric configuration of 
targeted equipment) as well as on sample and component properties to be tracked (e.g., 
chemical composition, physical features, state, concentration). It is also clear that monitoring 
multicomponent mixtures can be challenging because of component-component interference 
[108]. In light of these constraints, NIR and Raman spectroscopy are often chosen (many APIs 
are responsive to such techniques), but the results of visible imaging [76], fluorescence [49], 
focused beam reflectance [109] and acoustic emissions [110] have also been reported. Except 
for visible imaging which is mainly used in packaging (although some have demonstrated its 
utility as a PAT tool in coating [74], blending [78] and granulation [111] processes), most of 
these techniques have been tested in drug product manufacturing.  
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4.1.1 Application of PAT tools in the compression stage 
A literature search has shown that, in comparison to other manufacturing stages (e.g. 
blending, drying), the compression phase has not been explored extensively despite its many 
advantages. While 70% of pharmaceutical dosage forms are tablets [112], tableting has seldom 
been considered for PAT applications. Being the final step in the manufacturing chain, where 
the product can be accessed in powder form, quantitative control at this stage might make it 
possible to avoid further and unnecessary testing of the final product, potentially leading to 
real-time product release [113] (dissolution testing is often mandatory). Monitoring of powder 
entering the dies could provide information on phenomena occurring in powder blends during 
discharge through the hopper or inside the feed frame (mainly segregation and agglomeration) 
[86]. In segregated batches, it is expected that significant differences exist in the 
concentrations of ingredients within powders that can be detected by the right PAT tools 
[114]. They also make it possible to study powder flow dynamics [52] inside the feed frame, 
which can be of particular interest in the development stage, especially in relation to 
laboratory powder rheology testing [115]. In fact, different powders are expected to have 
different flow kinetics because of their properties (such as particle size and shape, density), the 
environment (external humidity) and interaction between them and the feed frame (attrition). 
Since free flowing powders tend to move freely and allow faster mingling, powder kinetics are 
expected to change in environments that potentiate their mixing (paddle-driven, forced 
movement). 
Most work on the compression stage has been centered on quantifying tablet composition 
by NIR [68] and Raman spectroscopy [116], rather than via in-line monitoring of flowing 
powder passing through the press. However, some studies have demonstrated that powder 
monitoring is possible at this stage of the process. Ward et al. [65] assessed circulating 
powders present in the feed frame and reported the possibility of quantifying APIs by NIR. 
They related the signals obtained with component concentrations. Wahl et al. [16] tested NIR 
in the feed frame and detected segregation in mixtures being processed. 
In CHAPTER 3, the possibility of monitoring powder components in the feed frame with 
NIR, LIF spectroscopy and RGB color imaging is suggested. In that work, the relative 
concentrations of a 6-component powder blend were varied. All 3 probes were able to monitor 
the composition of certain blended components. RGB imaging tracked color components, NIR 
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traced some relatively organic high-concentration components, and LIF followed low-dose 
fluorescent components. Our study disclosed the potential of LIF as a PAT in laboratory 
settings. Moreover, LIF discerned a broad range emission spectrum, which contributed to 
overcoming the lack of specificity of some equipment in tracking these components. It is also 
possible to integrate a selective excitation band and thus increase component selectivity. 
Despite upgrades of these technologies, the general deployment of LIF must take into account 
the interference that some components might present (especially the colored ones) in the 
resultant signal as well as other sources of variability, such as particle size distribution and 
moisture [53]. In this sense, multivariate techniques and spectral range selection can quantify 
and increase the specificities of tracked components. All these features make LIF a powerful 
tool for monitoring low-dose components (as low as 0.1% w/w) [101]. 
In the present work, 3 different PAT tools (NIR, LIF and RGB) were installed in the feed 
frame of an industrial tableting press to monitor the composition of 5 key components (beta-
carotene, riboflavin, ferrous fumarate, ginseng and ascorbic acid) of a 31-component powder 
blend indicative of typical multivitamin blends. First, this study seeks to ascertain if these PAT 
tools are capable of detecting composition step changes in complex multicomponent blends. 
Second, it attempts to determine if they can quantify powder flow dynamics inside the feed 
frame.  Our investigation of dynamic behaviour is intended to evaluate if small concentration 
differences between batches significantly alter powder throughput rates, a step forward in 
better process understanding.  
 
4.2 Materials, methods and techniques 
4.2.1 Experimental feed frame set-up 
A 37-station Manesty Novapress rotary tablet press was employed in this study. Using 19 
of the stations to limit unnecessary powder consumption, its speed was set to produce 530 
tablets/min. Tablet weight was adjusted to 1.76 g in every run. The feed frame of the press 
consisted of 2 intermeshing wheels with 10 paddles rotating at 20 rpm. The PAT tools were 
located on top of the feed frame, right before the powder exited to the dies, to best represent 
tablet composition.  
The PATs involved were: NIR (Viavi MicroNIRTM Pro 1700 ES, 900-1,700 nm, 6.2 nm 
resolution), RGB camera (5 MP Basler Pilot piA2400-12gc) with light system, and LIF 
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Both NIR and RGB (including the light system) were controlled by Labview software, 
while LIF data were acquired by NovaPac software from Prozess Technologie. 
 
4.2.2 Component selection and description  
A commercial 31-component mixture, composed of vitamins and minerals, served as 
reference blend throughout the study. This mixture was selected not only because it contained 
suitable components to be monitored by NIR, LIF and RGB, but also because its complex 
composition represented an important test of tool adequacy in industrial contexts. From this 
mixture, 5 vitamins (beta-carotene, riboflavin, ferrous fumarate, ginseng and ascorbic acid) 
were selected for quantification throughout the study by alternately overaging their 
concentrations. Pyridoxine, another vitamin, was the 6th component: its concentration was 
varied at 2 levels, although it was not quantified in this work. Its inclusion in the study 
attempted to assess detection by the analytical tools as an indication of their eventual 
quantification capacity. Table 4.2 presents the usual concentration range of selected vitamins in 
this type of formulation. 
 
Table 4.2: Reference values of tracked vitamins 
Vitamin 
Beta-
carotene 
Riboflavin 
Ferrous 
fumarate 
Ginseng 
Ascorbic 
acid 
Pyridoxine 
Concentration % 
(w/t) 
<1.0 <2.0 2.0-8.0 2.0-10.0 5.0-15.0 <1.5 
 
To select these components, the NIR response, color and fluorescence properties, along 
with PAT tool characteristics (sensitivity, detection limit), were taken into consideration to 
ensure that at least one of the tools could monitor each component. Along with these criteria, 
vitamins with a different concentration range (from low-concentration beta-carotene, 
riboflavin and pyridoxine to high-concentration ascorbic acid) were selected to test the 
detection limits of the PAT tools in a complex matrix and to ensure that some of them would 
be detectable.  
Riboflavin, ferrous fumarate and ascorbic acid were expected to present a NIR signal, but 
riboflavin concentration could prevent its detection. The fluorescent properties of riboflavin, 
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About 7.5 kg were prepared for each batch, taking into account a validated pharmaceutical 
manufacturing process with equipment and time adapted from proprietary, industrial, scale-
down methodology. The experiments called for the consecutive addition of each batch to the 
hopper of the tableting press when the quantity of powder remaining from the previous batch 
ran down. Timing of the change was triggered by an automated low powder-level sensor 
installed on the press. 
 
4.2.4 Data treatment 
 Preliminary selection 
The 15 batches analyzed represent a total of 1,209 observations: 1 acquisition at each 6 s 
(around 80 observations per batch). The 3 probes were positioned in rapid succession to 
ensure that they had: 1) acquired equivalent samples, and 2) gathered the same number of 
acquisitions. Some observations were excluded from the analysis when powder levels were 
too low. As batch change-over took place after the machine detected low powder levels in the 
hopper, some acquisition occurred during out-of-specification conditions. These periods could 
easily be identified in the data as they drastically altered the spectral characteristics of the NIR 
and LIF probes and led to unfocused RGB images. After these exclusions, 1,008 observations 
were recorded in the study. It is worth mentioning that faulty acquisition by one of the tools 
excluded the time point as a whole so that correspondence between observations and tools 
remained unaltered. 
In NIR and LIF, this step was straightforward and gave matrices of 1209×255 (LIF) and 
1209×126 (NIR). In RGB, 3D image data (consisting of red, green and blue signals for each 
pixel) were analyzed by MIA as reported by Macgregor et al. [34], and converted to matrices 
of 1209×1024.  
 
 Model points selection 
Since composition was altered by sequential step changes, a transitory period between 2 
steady-states was expected (Figure 4.3).  
Acquisitions were therefore divided into 3 distinct datasets: transition points (red 
symbols) served to evaluate powder flow dynamics but not to characterize model fit as true 
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vitamin was responsible for the addition of noise to the total model. Before building the 
models, NIR data were pretreated with SNV followed by auto-scaling, RGB data were 
pretreated with MIA and auto-scaled, and LIF data were treated with a first-order Savitzky-
Golay filter followed by auto-scaling. All data were treated and models built with PLS 
Toolbox and in-house Matlab software. 
 
4.2.5 Dynamics 
To study powder flow dynamics, data from all tools were combined and PLS models were 
built for each of the vitamins (except pyridoxine). The tools were combined because not only 
did they provide the best prediction (discussed in CHAPTER 3) in comparison to their use 
alone but also because preliminary modelling showed that all 3 probes identified similar 
powder dynamics for any given transition. The concentration step changes throughout this trial 
created transition periods. The study consisted of selecting time periods when the 
concentration of a given vitamin was changing by plotting predicted concentration through 
those transition periods. A kinetic equation was fitted to calculate its rate constant (k). Owing 
to the nature of our study design, 3 different transitions were observed for beta-carotene, 
riboflavin, ferrous fumarate and ginseng, with 4 transitions for ascorbic acid. 
As in a previous work [104], a first-order kinetics model was found to adequately fit 
concentration transitions observed in trial design. The formula is defined in Equation 4.2: 
 
?̂? = 𝐴𝑒𝑥𝑝(−𝑘𝑡)  Equation 4.2 
 
where ŷ is predicted relative concentration (dimensionless), A is gain (dimensionless), k is 
the rate constant (s-1) and t is time (s). 
 
4.2.6 Chemometrics 
 PLS 
Chemometrics are intimately connected with PAT due to the amount of correlated data 
these tools generate. PLS analysis is one of the most documented methods because of its 
success in establishing relationships between observation X (N×K) and one or more attributes 
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in study Y (N×M), such as the concentration of an ingredient. In its mathematical 
development, it seeks to maximize covariance between X and Y through the development of 
score T (N×A), where A is the number of components), and W is loading weight (K×A). In 
this study, the PLS technique was applied to generate models for the prediction of different 
vitamins. 
When working with multiple datasets, as is the case here with NIR, LIF and RGB, it is 
often relevant to merge the data into a single large X matrix after adequate scaling. While this 
may improve final prediction, the individual contribution of each original data matrix is lost. It 
may therefore be interesting to maintain the individual identity of the original data blocks in 
the model in the form of a mbPLS model. 
 
 Multiblock PLS 
Data concatenation is useful when several data sources are in place. Since several tools 
were used in this study (NIR, LIF and RGB), it is possible to include the technique and 
therefore merge all information in a single matrix. However, although simple PLS analysis is 
often conducted to obtain the model, it is helpful in certain cases to differentiate some blocks 
(usually defined parts of data coming from different tools) of merged data to collect 
information. In this case, mbPLS analysis may be considered [20]. In such mathematical 
development, prediction does not improve when compared to regular PLS analysis, but it is 
possible to interpret the amount of variance coming from each block and contributing to the 
overall value of prediction. Its mathematical development is based on PLS being the greatest 
difference with the merging of scores calculated from each block into a larger matrix T (super-
block), so that: 
 
𝑻 = [𝑡1 𝑡2 … 𝑡𝐼]  Equation 4.3 
 
T is then used to compute super weights (WT
T) which describe the relative importance of 
each block [117]. Figure 4.4 shows the schema of mbPLS mathematical development. 
When only 1 variable is modelled (as is the case in this work), steps 6 and 7 of Figure 4.4 
are redundant since u equals Y. 
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The equation shows that ∑𝑘𝐵𝐼𝑃𝐾
𝑁(𝐴))2 =  𝐵, which determines that a block with a 
number higher than 1, represents an important contribution to the model. 
 
4.3 Results and discussion 
4.3.1 Model building 
 Analysis and interpretation 
The analysis of each PLS model began with the qualitative evaluation of score plots. This 
step aimed to identify batches containing overaged vitamins in the plot and to determine if any 
other batches stood out, indicating potential interactions between certain components that may 
have an impact on the developed model. Therefore, the score plot presented a preliminary 
indication of the potential of the vitamin to be monitored, but no definitive conclusions could 
be drawn without qualitative analysis of the calibration and test samples. 
To illustrate data analysis, the model obtained with NIR for ferrous fumarate was used 
throughout this section. The score plot of the first 2 PCs is presented in Figure 4.5 and 
illustrates typical representation of this experiment. 
In the plot, different concentrations of ferrous fumarate (batches 10 and 11: 35% and 70% 
of overage) are grouped by color and style. Clear separation is seen between them and the rest 
of the batches, especially along t1 (37.75% of variance explained). However, although the 
model is built in relation to ferrous fumarate, 4 other groups of observations (surrounded by 
circles in the mentioned figure) are identified. They correspond to batches 6, 9, 14 and 15. 
While these batches all have the same nominal concentration of ferrous fumarate, their 
matrices are different enough to be detected as different entities. However, only batch 14 
varied along t1 (like overaged batches 10 and 11), which is an indication that the vitamin 
overaged in this batch might have a negative impact on the prediction of ferrous fumarate. 
Therefore, although t2 explains 40.71% of existent variance, the effect of batches 6, 9 and 15 
in predicting ferrous fumarate in the model remains unclear. 
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underestimations of predicted concentration. The decreased bias in Figure 4.7 (b), observed 
throughout the analyses, clearly underlines the advantages of multiple PAT probes in 
monitoring complex blends.  
 
 Model results and BIP values 
The predictive power of PLS models is represented by their adjusted R2 values. Table 3 
reports the adjusted R2 for calibration and the test points for each vitamin in study according to 
the number of components, using individual data (from each tool individually) as well as 
through their combination (i.e., data concatenation), with all 3 probes, or, when appropriate, 
the 2 most useful tools for a given product. 
 
Table 4.3: Adjusted R2 values for predictive models of the vitamins (Cal.: calibration; PC: principal 
components. Background color represents the best tools for each case) 
 
NIR RGB LIF 3 tools combined 
2 best tools 
combined 
Cal. Test PC Cal. Test PC Cal. Test PC Cal. Test PC Cal. Test PC 
Beta-
carotene 
0.25 0.20 6 0.49 0.44 3 0.91 0.88 8 0.93 0.84 8 - - - 
Riboflavin 0.34 0.22 6 0.78 0.62 4 0.95 0.99 4 0.96 0.94 5 0.97 0.94 5 
Ferrous 
fumarate 
0.97 0.96 6 0.96 0.93 4 0.94 0.94 4 0.97 0.97 2 0.96 0.96 3 
Ginseng 0.94 0.93 6 0.63 0.44 4 0.97 0.96 5 0.96 0.94 4 0.96 0.95 4 
Ascorbic 
ccid 
0.89 0.86 7 0.54 0.10 5 0.91 0.90 7 0.94 0.88 6 - - - 
 
Beta-carotene, present in low concentrations (<1.0 w/t %), appears reddish-brown to the 
human eye. According to the results, LIF was the only tool capable of predicting it, although 
the adjusted R2 value (R2cal = 0.91) was correlatively low compared to the other vitamins. 
However, since beta-carotene is not fluorescent, this value is likely the result of a phenomenon 
called auto-absorption (in the visible region) due to its color [53]. RGB and NIR were not 
expected to monitor beta-carotene considering its low concentration. For these reasons, data 
concatenation did not significantly improve the predictive capabilities of the models (R2cal = 
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0.93) and, since neither NIR nor RGB gave good results, none of the tools was able to predict 
the vitamin at this concentration. 
Riboflavin (yellow) was also present in low concentration (<2.0 w/t %). For the same 
reason and due to its fluorescence properties, LIF was the only tool that delivered good 
prediction. Nevertheless, its prominent color allowed RGB to detect some variation, but its 
low concentration prevented better prediction with this tool alone. When all data were 
combined, with more PCs (4 vs 5), the accuracy of the calibration model increased (R2cal = 
0.96) in opposition of what happened with the test set. When only the 2 best tools were 
combined (RGB and LIF), and for the same number of PCs, the model slightly increased 
prediction (R2cal = 0.97) in comparison to the values obtained when all tools were combined. 
Although the difference was not very large, it was an indication that the presence of NIR data 
added noise to the model, decreasing its predictive power. 
As far as ferrous fumarate (reddish-brown and 2.0-8.0 w/t %) is concerned, it could be 
monitored by all 3 tools. In fact, its chemical composition and concentration above the NIR 
detection limit allowed it to be monitored by this tool (R2cal = 0.97). Also, its color was critical 
for RGB tracking (R2cal = 0.96), and the reported influence that color has on the LIF signal 
justified its result (R2cal = 0.94). Since all tools were able to monitor it (although LIF might be 
considered a misleading model), analyzing all data simultaneously led to an increase in model 
accuracy at the same time as the number of PCs was decreased (R2cal = 0.97, 2 PCs). A similar 
conclusion was drawn when the 2 most suitable tools (NIR and RGB) were combined (R2cal = 
0.96, 3 PC). These results show that although the difference was not significant, removal of a 
tool which has good prediction power caused a decrease in the R2cal result of the combined 
model (NIR and RGB). 
Ginseng (light brown color) was present in a concentration range of 5.0-15.0 w/t %. Its 
chemical composition and fluorescence properties made it a suitable candidate to be monitored 
by both NIR and LIF. In this case and despite its color, the RGB tool could not monitor it, 
probably because of the staining effect rather than a defining effect it had on the mixture. The 
combined data from all tools confirmed the already good results obtained with these tools 
alone (R2cal = 0.97, 5 PCs). When the 2 best tools were combined (NIR and LIF), and for the 
same number of components, R2cal remained constant, but R2val improved slightly. As with 
riboflavin, there was a slight difference of R2 values between combined data with 2 or 3 tools, 
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although it was also true that combination not including the tool with the worst prediction 
(RGB) presented better results. 
As for ascorbic acid (5.0-15.0 w/w %), it is white and known to be NIR-responsive. 
Therefore, NIR but not RGB was able to monitor it (R2cal = 0.89). As in situations where the 
component in study was not fluorescent, the R2 value obtained with LIF was justified by the 
color variation of the mixture (adding ascorbic acid will dilute the concentration of the other 
components), leading to a misleading model with this tool. 
In the case of pyridoxine, its low concentration and fluorescent properties made LIF the 
only suitable tool to track it. Thus, the initial goal set was to detect a change in the LIF signal 
after varying its concentration. However, as mentioned earlier, ferrous fumarate also has a 
significant LIF signal which biases the pyridoxine signal (see concomitant variation of these 
components in batch 12). Therefore, a conclusion about LIF’s potential in monitoring 
pyridoxine would still be speculative and it is left for future study. 
These results show that the combined use of at least 2 PAT tools can improve component 
predictions, often without increasing mathematical complexity of the models (number of PCs). 
However, it is not always possible, or desirable, to deploy multiple PAT tools to monitor a 
process. In this sense, the tools that are more important must be evaluated by mbPLS models. 
Table 4.4 reports significance of the BIP values (BIP values of significant tools >1) of each 
tool based on the PLS models presented in Table 4.3, developed for each of the vitamins, when 
data from all tools are combined [119]. 
 
Table 4.4: BIP values of data combined for the vitamins in study 
Vitamins NIR RGB LIF 
Beta-carotene 0.96 (0.79-1.13) 1.00 (0.82-1.16) 1.05 (0.90-1.22) 
Riboflavin 0.67 (0.48-0.90) 1.05 (0.84-1.27) 1.28 (1.13-1.44) 
Ferrous fumarate 1.39 (1.29-1.51) 0.87 (0.75-1.00) 0.74 (0.66-0.82) 
Ginseng 1.17 (1.00-1.34) 0.48 (0.35-0.63) 1.36 (1.13-1.53) 
Ascorbic acid 1.21 (0.92-1.45) 0.61 (0.45-0.80) 1.18 (1.00-1.41) 
 
Through analysis of the results in Table 4.4, the significance of each tool in this 
combination matrix for the prediction of each vitamin could be highlighted. As for beta-
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carotene, the fact that the model developed was not as good as others made the information 
non-significant relative to its contribution. Although LIF demonstrated better prediction (as 
mentioned, its prediction was due to other causes), it was observed that the contribution of the 
other tools was also significant, despite their low predictive power when used alone. This 
information raises the possibility that the vitamin might be monitored by these tools in 
different conditions (e.g., a less complex type of matrix, a more concentrated component). 
Riboflavin’s color and fluorescence properties made it detectable by these tools with greater 
significance than NIR, which probably might be related to its low concentration in the 
mixture. The inverse occurred in the case of ferrous fumarate, as NIR demonstrated that it was 
a more adequate monitoring tool. Finally, ginseng and ascorbic acid had a larger possibility of 
being detected with NIR and LIF. Overall, as expected, it might be concluded that tool 
selection must depend on the vitamin to be monitored, its specificity for the technology used, 
with vitamin concentration being an important factor in the decision. LIF monitoring is 
preferable when concentration is low and fluorescence properties are apparent. RGB 
monitoring was demonstrated to be less efficient, although it was able to show a significant 
contribution with a low concentration component, such as riboflavin. Therefore, it might be a 
tool to consider when the component in study has color and no fluorescent properties. As for 
NIR, a significant contribution of the models was demonstrated, except in cases when the 
vitamin concentration in study was low (beta-carotene and riboflavin). 
 
4.3.2 Dynamics 
 Feed frame as ideal vessel 
The rheological properties of each component present in powder (particle size, shape and 
density) can influence its relative flow and behavior as a whole. Therefore, different 
concentrations of the same component in a multicomponent powder, like the one used in this 
work, might present different flow dynamics. Figure 4.8 illustrates the transition observed 
(from batch 10 to 11), using the predicted concentration obtained with our example (NIR and 
ferrous fumarate), with a first-order equation (red curve) fitted by minimization of the sum of 
squared errors (SSE). The k of the real vessel calculated through Equation 4.2 had a value of 
0.067 s-1 (0.056-0.076, with 95% CI). If continuous stirred-tank reactor behavior of the feed 
frame is considered, and taking into account powder density, the total and constant volume of 
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4.4 Conclusion 
The objective of this work was to monitor the composition of certain key components in a 
multivitamin powder blend in the feed frame of a tableting press in real time. Three PAT tools 
monitored the circulating powder blend: LIF, NIR and RGB color imaging. 
Of the 31 components present in the blend, 5 (beta-carotene, riboflavin, ferrous fumarate, 
ginseng and ascorbic acid) were chosen and monitored in situ with multiple composition step 
changes. Four of the 5 vitamins, all present in industrially-relevant concentrations, could be 
monitored by at least one of the tools, according to their physical characteristics (e.g., color) 
and concentrations. The combination of more than one tool (i.e., via data concatenation) made 
it possible to limit validation bias, enhancing model quality. With tool combination, all models 
developed were validated with an adjusted R2 value higher than 0.83 and up to 0.97 with just 2 
PCs. The results demonstrate the potential of these tools to be implemented in the feed frame 
for monitoring concentrations. 
The flow dynamics of each transition were evaluated and calculated with first-order 
model kinetics. No significant differences in circulation rates were detected between 
components, probably owing to high complexity of the blend, the relatively small changes in 
overall blend composition, and the small rheological differences caused by these variances. 
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Summary 
Contents: In the previous chapter, the potential of the tools to quantify certain components was 
evaluated, even if they are part of a multicomponent blend and / or present in low 
concentration. However, to implement this technology as monitoring / control tools, the 
models developed must take into consideration all the variations that can occur in the process. 
Therefore, it is essential that a good design is built to obtain a robust model and therefore 
accurately predict the target component. This chapter is aimed at evaluating the specificity of 
these tools to the component intended to be monitored. Using an off-line testing, two full 
factorial designs of four vitamins were applied to evaluate the accuracy of the models built 
and assess any potential interference that could exist in the signal obtained from these tools.  
 
Results: As expected, since a significant difference in design was established in comparison 
with the one studied in the previous chapter (simple step change in chapter 5 vs a full factorial 
design in the present chapter), the models developed presented a lower R2. However, if the 
complexity of the blend is considered, the results demonstrated a good selectivity for the 
targeted components. Nevertheless, some interference (especially in the LIF tool) was 
identified and although it did not prove to be statistically significant, special attention to this 
factor must be taken in future implementations. 
 
Contributions to the thesis: This chapter intends to propose a general method to evaluate PAT 
robustness. To do that, the 3 tools were used to evaluate the selected components in the 
multicomponent blend used, in order to track them with an acceptable degree of accuracy, 
taking into account the regulatory environment. For other blends (those whose stricter 
regulation), it is importan0t to take into account certain interferences that might occur and that 
could deplete the required selectivity of the tools. The interference occurring when LIF is 
applied might play an important role in the prediction of the target component. 
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Abstract 
The application of Process Analytical Technologies in pharmaceutics manufacturing has 
been the subject of many studies. Active pharmaceutical ingredient monitoring in real time 
throughout the manufacturing process is commonly the target of many such implementations. 
The tools in place must be sensitive to, and selective of, the parameter(s) to be monitored, i.e., 
in the case of component quantification, they must be sensitive to the component in question 
and robust against all others. In the present study, 4 different ingredients (riboflavin, ferrous 
fumarate, ginseng and ascorbic acid) in a multicomponent blend were monitored by 3 different 
tools (near infrared spectroscopy, laser-induced fluorescence, and red-green-blue camera) 
using a full factorial design. The goal was to develop efficient and robust concentration-
reading/prediction models able to assess and monitor component interference. Despite 
relatively high complexity of the blend studied, the 3 tools demonstrated reasonable specificity 
for the tracked ingredients, taking into account larger acceptance criteria typical of dietary 
products. In certain cases, some interference might lead to biased predictions, highlighting the 
importance of good calibration. The tools tested and the methodology proposed have divulged 
their potential in monitoring these components, despite the complexity of the 31-component 
blend. 
 
Keywords: Process analytical technology; near-infrared; light induced fluorescence; color 
imaging; specificity; interference 
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Résumé français: 
Les recommandations des institutions de réglementation sur la mise en œuvre de 
la “Quality by Design” et les avantages qui en découlent dans le développement 
pharmaceutique, en particulier dans la phase de production, conduisent l'industrie 
pharmaceutique à appliquer des PAT dans leurs procedés. La surveillance de l’API en temps 
réel tout au long du procédé de fabrication est habituellement la cible de plusieurs de ces 
implémentations. Les outils mis en place doivent être sensibles et robustes aux paramètres à 
surveiller, c'est-à-dire, dans le cas de quantification d'une composante, ces outils doivent être 
sensibles à la composante et sélectifs à tous les autres, ce qui est influencé par la complexité 
de la matrice. 
Dans cette étude, quatre différents API (riboflavine, fumarate ferreux, ginseng et acide 
ascorbique) présents dans un mélange multicomposant ont été monitorisés par trois outils 
différents (spectroscopie proche infrarouge, fluorescence par laser et caméra rouge, vert et 
bleu) utilisant un plan factoriel complet. L'objectif est de développer un modèle d’acquisition / 
prédiction de concentration efficace et robuste, capable d'évaluer et de prendre en compte 
l'interférence des composants surveillés. Malgré la complexité relativement élevée du mélange 
étudié, les outils ont démontré une spécificité modérée pour les ingrédients étudiés, en tenant 
compte des plus grands critères d'acceptation spécifiques aux produits diététiques. Néanmoins, 
dans certains cas, une certaine interférence pourrait conduire à des données biaisées, mettant 
en évidence l'importance d'un bon plan de calibration. Les outils testés et la méthodologie 
proposée ont démontré leur potentiel dans la surveillance de ces composants, malgré la 
complexité du mélange. 
 
Mots-clés: PAT, NIR, LIF, RGB Imagerie, Spécificité, Interférence
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5.1 Introduction 
Pharmaceutical manufacturing companies are increasingly aware of the benefits of 
replacing conventional product testing (usually based on laboratory work – UV spectroscopy, 
HPLC) by state-of-the-art PAT. The latter provides non-destructive analysis, statistically 
representative process sampling and real-time information [120]. Regulatory 
recommendations have been directing pharmaceutical product development, specifically 
manufacturing steps towards process monitoring and understanding its limits rather than 
focusing on the product itself [5], which is at the heart of PAT. This approach, which defines 
QbD as the methodology to be followed in pharmaceutical development, assigns an essential 
role to PAT to obtain as much information as possible throughout the development process 
and the optimization of existing processes. Therefore, PAT: 
(a) in the case of a new product, can be part of the first development stages (API definition 
[121] and characterization [122] – identification, impurity detection, crystallinity, humidity 
level) – or even applied through the final development stages, and 
(b) in the case of already-available commercial formulations, can serve to redesign, 
monitor and control existing manufacturing processes. 
Successful PAT implementation largely depends on the identification of CQA – 
“physical, chemical, biological or microbiological property or characteristic that should be 
within an appropriate limit range, or distribution to ensure the desired product quality” [2]. In 
fact, through risk analysis [3], CQA are identified and tested (design space), defined (control 
space), monitored and controlled by PAT tools. Once CQA or CPP have been identified, the 
first step in PAT implementation is tool selection for monitoring via a feasibility study. 
In PAT implementation during the manufacturing stage, many CQA might be adapted 
with prior knowledge of similar processes, such as water quantity and particle size in wet 
granulation [93] or API quantification in blending [91]. However, tool selection to monitor 
CQA is strongly product-dependent. For instance, in component quantification, the choice of 
monitoring tool depends on its response to that tool. In these processes, NIR is largely 
accepted as a tool to monitor water content [93] while several techniques (NIR [98], Raman 
[123], LIF [53]) have demonstrated suitable characteristics and high potential in API 
quantification. 
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5.1.1 Design considerations 
Although published data indicate which tools might be used to monitor certain CQA, 
process and product specificity make preliminary feasibility studies imperative in PAT 
implementation. Since PAT tools to monitor CQAs are usually identified through the 
evaluation of model accuracy, it is critical to take robustness into consideration, so that tool 
potential can be correctly assessed. On this subject, and given the common use of multivariate 
techniques, such as PLS in model development, Xiang et al. [124] pointed out the importance 
of calibration in model building. In their study, which analyzed API in tablets with NIR as 
monitoring tool, the importance of a randomized design was highlighted, not only as a way to 
reduce the potential of chance correlations (correlations not related to the target parameter, 
between process data (X) and predicted parameter (y)), but also to increase model specificity. 
It proved that randomized designs presented better specificity with varying parameter values, 
such as excipient and hardness, than correlated designs. The problem of correlations in 
calibration design was demonstrated in other fields by Rhiel et al. [125], as models developed 
in ovary cell cultures, based on samples with high correlations between metabolites, only 
worked if that same correlation was maintained.  
In fact, creating ideal conditions to achieve the correct design could be difficult and would 
be even harder when a complex mixture is assessed. In case of mixtures with several 
components, their study requires calibration runs to take all variables into account, increasing 
the number of necessary experiments to obtain reliable results, especially when components 
within the blend do not have clearly distinguishable features and/or lead to a distinguishable 
response by a given monitoring tool. Design of experiment (DoE) techniques are important to 
overcome this problem and reduce the number of runs that a full factorial design would 
demand [126]. Scheibelhofer et al. [127] underscored the dependence of model performance 
on chosen DoE. In some cases, despite lacking in robustness, simpler designs are intended to 
investigate general effects [128], especially when a PAT tool is used to determine the entire 
blend as a sum of its APIs and excipient [129], relative to others that monitor a specific 
component [130]. 
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5.1.2 Specificity of PAT tools 
The quantitative prediction of components (usually an API) is the most common CQA 
described in the literature. Often, a single PAT tool monitors several components in blends by 
multivariate techniques [129][131][132]. However, the goal is usually to monitor the blend as 
a whole (as a result of all interactions established between all components of the blend and the 
monitoring tool), as in the determination of mixture endpoints, and not to develop a method to 
individually quantify each component. To do so, regulations require analyte assessment for 
technique specificity [41][17]. All too often, this requirement is not considered extensively in 
published reports. In model development of API quantification, agents potentially interfering 
with the tool are usually not included in model design and are commonly replaced by binary or 
tertiary mixtures [133], so that the possibility of interference with other components is 
decreased. This indicates potential, but does not challenge the tool with more difficult, i.e., 
realistic, conditions. 
Tool selection must take into consideration: (a) the CQA intended to be monitored (b) the 
environment (humidity, matrix complexity), (c) their own features (in which their specificity 
and accuracy to the CQA play a critical role), and (d) evaluation after adequate experimental 
design. In the present work, we propose to test a multivitamin blend with different 
components, employing 3 different PAT tools: NIR, RGB imaging and LIF. Despite its 
common use as a PAT tool, NIR is less specific than other spectroscopy tools, such as Raman 
or Fourier Transform Infrared owing to the fact that the peaks are generally the result of 
contributions from chemical groups in more than 1 tracked component of the analyzed mixture 
[134]. However, the fact is that it is both non-destructive and contains characteristic bands, 
making it possible to identify and quantify the component. Thus, NIR is the most widely-used 
tool in every step of manufacturing processes. LIF specificity might be enhanced if the 
equipment is capable of varying the range of excitation and emission specific to each molecule 
[53]. In the RGB imaging, specificity depends on spatial resolution of the camera and is highly 
affected by color similarities between components. 
Work described in CHAPTER 4 demonstrated the potential of these tools to quantify 
components in complex mixtures. A multicomponent blend enhanced the inherent difficulty in 
tracking a single component because of possible signal overlapping. Four components were 
successfully modeled (riboflavin, ferrous fumarate, ginseng, ascorbic acid) based on data 
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obtained in-line in a feed frame tablet press by alternately changing the concentration of each 
component in the study. However, the DoE in this study did not consider the potential impact 
that simultaneous variations in the concentration of ingredients might have on the accuracy of 
the tool and, therefore, on the correlation that might exist between components. 
In light of the latter, the present study seeks to fill the gap by specifically assessing 
interactions that might occur between components of a single blend and evaluating model 
adequacy obtained through an extensive (full factorial) design. By testing the same complex 
mixtures used in the work developed in CHAPTER 4, as well as the same PAT tools, 
specificity of the latter is evaluated by identifying which ingredients can interfere with 
predictions of others, and determine how they are manifested in the results. The expected 
outcome is a general method to ascertain if confounding is present in a multicomponent blend. 
 
5.2 Materials and methods 
5.2.1 Equipment 
Powders were profiled by NIR spectrometer (Viavi MicroNIRTM 1700, 900-1,700 nm, 
6.2-nm resolution), RGB camera (5 MP Basler Pilot piA2400-12gc), and LIF spectrometer 
(Prozess Technologie, Model 801, 302–1149 nm, 3.4nm resolution; St. Louis, MO).  Table 
5.1. defines the parameters of acquisition. 
 
Table 5.1: Parameters of acquisition and sample spot size 
Equipment Integration time (µs) 
Number of averaged 
samples 
Spot size (mm) 
NIR 500 50 15 × 4 
LIF 80 1 4×4 (round) 
RGB 300 1 25 × 22 
 
NIR acquisition was undertaken with Viavi Labview-based software, RGB acquisition 
with “Measurement and Automation Explorer” (National Instruments) with images of 
2,454×2,056 pixels, and LIF acquisition with NovaPac software from Prozess Technologie. 
Acquisition was conducted off-line. NIR and LIF data were obtained by direct contact 
between the probes and sample (both with average penetration depth of about 1 mm, 
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depending on powder density), while RGB imaging data were acquired with previously-
determined, constant distance for clear and focused images. 
 
5.2.2 Selection and description of components to analyse 
A commercial 31-component multivitamin mixture was selected as the reference product. 
Four ingredients (riboflavin, ferrous fumarate, ginseng and ascorbic acid) from the mixture 
were selected for tracking and to study the application of PAT tools. Table 5.2 presents 
concentration ranges in these formulations. 
 
Table 5.2: Concentration ranges of ingredients under study: typical values of different multivitamin 
blends 
Component Riboflavin Ferrous fumarate Ginseng Ascorbic acid 
Concentration % (w/t) 0.0-2.0 2.0-8.0 2.0-10.0 5.0-15.0 
 
The ingredients were selected because they are common in dietary products and, at the 
same time, they have properties that are representative of many components in pharmaceutical 
formulations, especially in terms of particle size distribution, shape, and density differences 
between components that could enhance the segregation phenomenon. In addition, the 
components to be monitored were also selected by taking into account their physical and 
chemical properties detected by at least one of the tools in place. Therefore, NIR responses, 
color features (RGB imaging) and fluorescence properties (LIF), along with a different range 
of concentrations (to evaluate the capacity of these tools), were criteria for their selection. The 
same blend and ingredients were analyzed using these apparatuses in CHAPTER 4 with an in-
line configuration (i.e., powder flowing through the feed frame of a tabletting press). 
Riboflavin (yellow and fluorescence properties) was modeled by LIF despite its low 
concentration; ferrous fumarate (reddish brown color, NIR-responsive) by NIR and RGB; 
ginseng (NIR-responsive and fluorescent) by NIR and RGB, and ascorbic acid (NIR-
responsive) by NIR. These models were based on variation in concentration of a single 
component, one at a time, without considering interactions between ingredients, the aim of this 
work. 
 
 

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5.2.4 Batch preparation and data acquisition 
All batches were prepared from the same reference mixture taken from the manufacturing 
line (therefore prepared by a validated method). The reference mixture was then divided into 
34 batches (400 g each). The 4 ingredients were weighed and added to each batch to obtain the 
desired concentration, and the mixture was processed in a 4-L in-house-built blender using 
proper scaled-down methodology to define blending time (100 seconds). A representative 
sample of each batch was analyzed off-line by the 3 tools in place. 16 acquisitions per tool 
were achieved for every batch. 
 
5.2.5 Data treatment 
The 16 acquisitions obtained from each of the 34 batches (544 acquisitions per tool, in 
total) were divided equally into calibration and test sets. The NIR data were pretreated with 
Standard Normal Variate and scaled to UnV. RGB data were analyzed by MIA [34], then 
scaled to UnV. LIF data were treated with first-order Savitzky-Golay filter, then scaled to 
UnV. Therefore, a total of 12 PLS models were developed (4 components and 3 tools). 
Individual models, which gave better R2 values, were then characterized by residual error 
related to each parameter to identify which ingredients presented significant interference in the 
model developed (by ANOVA). After their selection, t-testing evaluated which ingredients 
possibly interfered in the monitoring of each ingredient by each tool.  
All data treatment, model building and statistical analysis were conducted with PLS 
Toolbox and in-house software using Matlab. 
 
5.3 Results and discussion 
5.3.1 Models building and selection 
As mentioned in Section 5.2.3, each ingredient studied had 4 different concentrations 
(levels) distributed in all batches. Concentration differences were known to be large enough to 
be detected by the tools. Therefore, when a PLS model is developed, and assuming that no 
interaction is present, it should be able to distinguish 4 distinct sample types, each clearly 
clustered in PLS score plots. On the other hand, if strong interaction could bias the data, the 4 
clusters would be blurred. Although score plot representation is purely qualitative, it 
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represents a preliminary conclusion of possible interference and must be observed for all 12 
PLS models developed.  
Considering, as an example, the score plot obtained for ginseng when NIR data were 
tested (Figure 5.2). In CHAPTER 4, this tool was shown to be able to monitor ginseng 
variations, keeping the ratios of all other components unchanged. In the present case, however, 
where such constraints were removed, it was observed that, as concentrations increased, the 
samples tended to shift to the right. This fact is much clearer at the highest level (yellow ◊) 
where samples are mainly located in the right top quadrant of the graph. However, not all 
samples at this level are located in that region as some appear in the center of the plot, along 
with others of lower concentration. It indicates that some interference may be occurring 
between ginseng and another compound when NIR is modeled. It might, in turn, lead to biased 
estimation of ginseng concentration. 
Analysis of score plots for all other models generally gave similar results (not presented). 
However, due to the qualitative nature of this analysis, few conclusions can be drawn from 
these results. For this reason, adjusted R2 was computed for each model as key indicator of 
model quality. Table 5.3 indicates the calibration and test values of adjusted R2 for the models 
built as well as the number of PC. 
 
  
Figure 5.2: Score plot of the PLS model of ginseng developed from NIR data (8 PC): sample 
concentration increased in the sequence of circles (red o), squares (light blue □), stars (dark blue ⁕), 
and diamonds (yellow ◊) 
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Table 5.3: Adjusted R2 values of models built (Cal.: calibration; PC: principal components) 
 
NIR RGB LIF 
Cal. Test PC Cal. Test PC Cal. Test PC 
Riboflavin 0.62 0.57 8 0.95 0.78 8 0.72 0.55 8 
Ferrous fumarate 0.85 0.83 8 0.95 0.70 8 0.73 0.64 8 
Ginseng 0.85 0.81 8 0.93 0.70 8 0.90 0.85 7 
Ascorbic acid 0.78 0.71 8 0.85 0.39 8 0.70 0.60 7 
 
From Table 5.3, it can be inferred which tools are better suited to monitor each ingredient. 
Riboflavin, which is yellow, present in low concentration (<2.0%) and fluorescent, was a good 
model when monitored by RGB (R2calibration = 0.95) and had lower values when monitored by 
LIF (R2calibration = 0.72). NIR was not able to accurately predict this ingredient, probably 
because of its low concentration in the mixture. As for ferrous fumarate, its brownish-red color 
and high concentration (2.0-10.0%) made it suitable for tracking by NIR (R2calibration = 0.85) 
and RGB (R2calibration = 0.95). As with LIF, although this ingredient does not have fluorescence 
properties, it can be predicted by its color outcome due to the visible spectroscopy effect, 
which is not recommended. The light brown color, intermediate concentration (2.0-10.0%), 
fluorescence properties and NIR-responsiveness of ginseng made it trackable by all tools. NIR 
was most accurate (R2calibration = 0.78) in the case of ascorbic acid, a white powder present in 
high concentrations (5.0-15.0%) among the ingredients studied, although RGB calibration 
gave a higher value (R2calibration = 0.85). However, RGB led to lower values (R2test = 0.39), 
preventing it from being considered as accurate (the white color of ascorbic acid makes it 
impossible for RGB to monitor since it is diluted in the blend). As with LIF, the absence of 
fluorescence in this component culminated in lower results obtained. 
 
Practical utility of the tools  
Analysis of the results in Table 5.3 reveals no surprises regarding the tools which are able 
to monitor each of the ingredients as they are in accordance with the conclusions obtained 
from CHAPTER 4. Therefore, assuming that R2≥0.70 represents acceptable fit for the model, 
taking complexity of the blend and the quantification tolerance of these components into 
account, riboflavin can be monitored by RGB and LIF, ferrous fumarate by NIR and RGB, 
ginseng by all tools, and ascorbic acid by NIR. Modeling of riboflavin by NIR (low 
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R2calibration), of ferrous fumarate by LIF (known interference of the tool with color components 
that give biased results) and of ascorbic acid by RGB (low R2test) and LIF (low R2calibration) 
proved to be ineffective. 
It can be observed that R2 values are generally lower (Figure 5.3) in comparison to the 
results obtained in  CHAPTER 4. This is attributed to design, since relative concentration of 
the ingredients remains constant, but varies in full factorial design. Although such is the case 
with NIR and LIF, RGB leads to better prediction in complex designs. These results must be 
interpreted very carefully since RGB is more sensitive to changes in acquisition conditions 
(process dynamics, vibrations), i.e., prediction is significantly different when the model is 
developed in-line or off-line. This fact may have improved RGB models for ginseng 
monitoring beyond the results obtained in CHAPTER 4. Finally, the higher R2calibration values 
obtained for riboflavin, when monitored by NIR in the present study compared to a simpler 
design, has no significance since the tool did not give adequate values in both cases. 
Interpretation of these R2 values must consider the constraints and the goal for which 
these tools are installed. A general overview indicates that all tools are capable of monitoring 
at least 1 ingredient (lowest value of 0.72 in riboflavin monitoring by LIF). Although this 
value appears low, it is important to consider that the model is developed for low-
concentration ingredients (<2%) present in a 31-component multivitamin blend after complex 
calibration. A previous study with a simpler design led to a R2calibration of 0.95 (CHAPTER 4). 
Moreover, these types of formulations, with a large number of components, are characteristic 
of dietary products (like multivitamins) and are rarely found in pharmaceutical formulations 
whose number of components is significantly lower. Along with the API, which is usually the 
component to be monitored, a typical tablet has few other excipients in its constitution, such as 
diluents, binders, desintegrants and lubricants, rarely higher than 10 in sum. Acceptance 
criteria are broader in dietary products than in pharmaceuticals (constituted by an API), mainly 
due to the degradation these kinds of products undergo throughout their shelf life [135]. 
Therefore, the margin of error of the models developed is likely within accepted criteria of 
these ingredients (criteria that mainly depend on the manufacturer). Taking all the mentioned 
constraints into account, the acceptability of these values also indicates the potential of these 
tools to more accurately monitor other components with the same characteristics in less 
complex blends. 
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To facilitate interpretation of the results, and since the significance of this analysis lay in 
study of the interference that the parameters alone might cause (A, B, C and D), interactions 
between them (AB, AC, AD, BC, BD, CD, ABC, ABD, ACD, BCD, ABCD) were not 
considered. The importance of each parameter on error in the models, described in Section 
5.3.1 as well, is enumerated in Table 5.4 where parameters that showed statistical significance 
(95% CI) are highlighted.  
Table 5.5 includes the outcomes to facilitate analysis. 
 
Table 5.4: Importance (%) and significance of each parameter in the selected models (Cont.: 
Contribution) 
 
Parameters 
Riboflavin Ascorbic acid Ginseng Ferrous fumarate 
Tools Ingredients Cont. p-value Cont. p-value Cont. p-value Cont. p-value 
NIR 
Ascorbic acid 0.4 0.873 16.8 0.005 4.6 0.208 3.6 0.292 
Ginseng 1.0 0.741 2.2 0.518 4.3 0.278 0.4 0.886 
Ferrous fumarate 3.6 0.318 1.2 0.673 0.2 0.933 16.3 0.008 
LIF 
Riboflavin 26.4 0.000 8.2 0.040 4.9 0.139 0.7 0.759 
Ginseng 1.5 0.616 0.5 0.844 9.6 0.057 6.1 0.154 
RGB 
Riboflavin 7.1 0.131 1.7 0.604 0.4 0.900 1.6 0.620 
Ginseng 0.5 0.865 1.9 0.583 2.9 0.445 1.1 0.744 
Ferrous fumarate 0.9 0.739 5.9 0.152 1.4 0.631 11.8 0.027 
 
 
Table 5.5: Possibilities of interference from Table 4 (bold underlined values are significant at α = 
0.05) 
 Summary 
Tools Ingredients 
Most significant parameters Possible interfering 
parameters 
NIR 
Ascorbic acid Ascorbic acid - 
Ginseng - - 
Ferrous fumarate Ferrous fumarate - 
LIF 
Riboflavin Riboflavin Ascorbic acid 
Ginseng Gingeng Ferrous fumarate 
RGB 
Riboflavin - - 
Ginseng - - 
Ferrous fumarate Ferrous fumarate - 
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As might be expected, the results first reveal that the most significant parameter affecting 
the prediction error of a component is the component concentration itself. In general terms, 
this can be explained by the fact that we are working with multiple concentrations, and 
extreme concentrations are slightly biased (e.g., high concentrations tend to be 
underestimated). 
The results show that secondary components sometimes also significantly affect 
predictions (riboflavin and ginseng monitoring by LIF). However, in other cases, they do not, 
even if they are responsive to the monitoring tool. Taking the model developed for ascorbic 
acid with NIR as an example, it is evident that, although other components (ginseng and 
ferrous fumarate) contribute to the error (4.6 and 3.6, respectively), probably because they are 
both NIR-responsive, the multivariate approach was able to build models without significant 
interference. 
Nevertheless, in ginseng monitoring, none of the models developed (for any of the tools) 
showed significant parameters, although with LIF, ginseng was nearly significant (p-value = 
0.057), unlike the other tools (p-values of 0.278 and 0.445 with NIR and RGB, respectively). 
These observations disclose that LIF is much more selective for ginseng than the other tools, 
despite goodness of the model obtained with NIR (R2calibration = 0.81). It is possible that the 
model developed with this tool might be the result of correlation of several parameters (NIR is 
responsive to all ingredients under study). 
The absence of parameter significance was also witnessed with component modeling by 
RGB, except in the case of ferrous fumarate. Such findings lead to the conclusion that, in RGB 
modeling, the error observed is largely method-related (many color components could 
correlate with this ingredient), which could eventually limit utility of the tool. 
It is also apparent from this work that parameters are only significant when their 
contribution is at least around 8% of error. Although this percentage cannot be generalized and 
mostly depends on study type (especially the DoE approach) and concentrations involved, it 
can be assumed that lower error percentages will not be significant. An obvious case is the 
model developed for riboflavin with LIF. In that case, 2 significant parameters can be 
observed: riboflavin with a contribution of 26.4%, and ascorbic acid with a contribution of 
8.2%. It clearly indicates that the presence of ascorbic acid might interfere with riboflavin 
prediction by this tool. Although there is no clear-cut explanation of this correlation, since 
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ascorbic acid does not have fluorescent properties and, thus, does not have the potential to 
directly affect the LIF signal, many other mechanisms can occur in such complex blends (e.g., 
increasing ascorbic acid concentrations lead to dilution of other fluorescent components). In 
contrast, certain components, expected to contribute significantly to modeling, do not seem to 
cause any interference, e.g., the presence of ferrous fumarate in ginseng monitoring by LIF, 
because of its color properties. However, in this specific case, ferrous fumarate contributes to 
error of 6.1%, which corresponds to the highest contribution of the non-interfering 
components of all models. Although not significant, the result indicates that some interference 
might actually occur, especially since the monitored ingredient is not significant as well. 
It is concluded that the latter 2 interactions – one mathematically significant, and the other 
making a high contribution – were most significant in the models developed and defined for 
testing. All other components proved to be non-important in the models developed. 
  
5.3.3 Determination of the interactions 
Analysis of residual errors makes it possible to determine which ingredients have the 
potential to interact with each other, but does not explain the concentration range in which 
interference plays a role, or the effect of that interference. These 2 factors are discussed in this 
section. 
The previous section noted that riboflavin modeling with LIF might be affected by the 
presence of ascorbic acid. Also, the possibility was considered that ferrous fumarate might 
have an impact on ginseng prediction when the same tool was tested. The effect of these 
interactions is depicted in Figure 5.4 (a) to (d), through calibration and validation curves of 
these models, using a color code system to identify concentrations of the interfering 
parameters (ascorbic acid and ferrous fumarate, respectively) present in each concentration of 
the studied ingredients (riboflavin and ginseng). Trial design in this work did not provide 
information on component interaction at lower concentration (level 0) with another component 
present in higher concentration (level 2) and vice versa. However, all the studied ingredients 
had 2 levels (0 and 2) at which interference was determined. At level 0 of the studied 
component, the interfering parameters were at levels 0 and 1, whereas at level 2 the interfering 
parameters were at levels 1 and 2.  Therefore, study of interference was possible by analyzing 
the results of modeling curves. Taking as an example the data presented in Figure 5.4 (a), it is 
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which might be an indication that their presence leads to riboflavin underestimation. As far as 
LIF monitoring of ginseng is concerned, it can be seen that, in both the calibration and 
validation curves, separation between samples with different concentrations of the interfering 
component is more obvious at lower ginseng level (level 0, 135%), than when the 
concentration of this component is higher (level 2, 300%). At this concentration, ferrous 
fumarate might have an effect on ginseng overestimation if ferrous fumarate is present. At 
higher concentrations (level 2), this influence does not seem so strong. 
 
Are they true interfering agents? 
To evaluate if the difference in position is significant between each group of samples with 
the same concentration of ingredient under study but varying concentrations of the interfering 
agent, t-testing was performed with unknown variance and 95% CI. Statistical differences 
between the averages of each pair indicate that the concentration of each interfering parameter 
plays a role in prediction of the ingredient to be monitored (riboflavin and ginseng, 
respectively). These tests were performed for both calibration and validation curves. As seen 
in Table 5.6 to Table 5.9, the only pair of statistically different samples (|t-value|>t-critical) is 
the interaction of ascorbic acid at the higher riboflavin concentration (level 2) in the 
calibration curve, and the interaction of ferrous fumarate with ginseng at the lower 
concentration of this ingredient (level 0). This proves that ascorbic acid concentration does, in 
fact, play a role in riboflavin prediction, although, as studied in the previous section, this 
parameter was not significant to the model. 
 
Table 5.6: t-test of the riboflavin model with LIF data (calibration) 
Component 
predicted 
Interfering 
component 
 
 
 
Riboflavin 
(concentration) 
Ascorbic acid 
(concentration) 
t-value 
t-critical 
(Unilateral) 
p-value 
0 
0 
0.90 1.77 0.19 
1 
2 
1 
-2.37 1.77 0.02 
2 
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Table 5.7: t-test of the riboflavin model with LIF data (validation) 
Component 
predicted 
Interfering 
component 
 
 
 
Riboflavin 
(concentration) 
Ascorbic acid 
(concentration) 
t value 
t critical 
(Unilateral) 
p - value 
0 
0 
-1.25 1.80 0.12 
1 
2 
1 
-1.64 1.76 0.06 
2 
 
 
Table 5.8: t-test of the ginseng model with LIF data (calibration) 
Component 
predicted 
Interfering 
component 
 
 
 
Ginseng 
(concentration) 
Ferrous fumarate 
(concentration) 
t-value 
t-critical 
(Unilateral) 
p-value 
0 
0 
-2.22 1.76 0.02 
1 
2 
1 
-1.14 1.77 0.14 
2 
 
 
Table 5.9: t-test of the ginseng model with LIF data (validation) 
Component 
predicted 
Interfering 
component 
 
 
 
Ginseng 
(concentration) 
Ferrous fumarate 
(concentration) 
t-value 
t-critical 
(Unilateral) 
p-value 
0 
0 
-1.39 1.76 0.09 
1 
2 
1 
-0.43 1.76 0.34 
2 
 
In the case of ascorbic acid interaction in riboflavin monitoring, its influence is most 
likely due to the dilution effect that higher quantities of ascorbic acid have on total 
fluorescence emitted by fluorescent components of the blend. Although this interaction seems 
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to occur only with higher quantities of riboflavin and ascorbic acid, it remains inconclusive 
since the calibration curve shows a significant effect of possible overestimation, whereas 
validation, despite the fact that it is not significant, is located below the calibration curve. This 
interference of ascorbic acid was not expected at the beginning of the trial and reinforces the 
need for robust model design in the late stages of implementation. 
As far as ginseng monitoring is concerned, the presence of ferrous fumarate seems to 
overestimate it at a low concentration. This effect vanishes when ginseng concentration 
increases, regardless of simultaneous increment of the interfering ingredient. It was expected 
because of the spectroscopic influence this component has on fluorescence. Being significant 
only in low doses, it is of utmost importance for monitoring ingredients with higher 
concentrations but might represent a setback when the goal is to monitor low-dose 
components in the blend. 
Therefore, it can be said that these components (ascorbic acid and ferrous fumarate) are 
likely to behave as interfering agents in prediction of the studied ingredients (riboflavin and 
ginseng, respectively) with LIF monitoring. 
 
5.4 Conclusion 
This work centers on the use of PAT tools to monitor multicomponent pharmaceutical 
powder blends. Specifically, it seeks to develop a method for studying model robustness (i.e., 
the predicted concentrations of a given component) when levels of the other components are 
free to vary. To illustrate the method, 4 ingredients (riboflavin, ferrous fumarate, ginseng and 
ascorbic acid), typically present in multivitamin blends, were monitored by 3 probes (NIR, 
LIF and RGB imaging).  
At least 1 tool was capable of accurately predicting the concentrations of all ingredients, 
showing that, even in complex mixtures usually found in multivitamins, such tools may 
represent an option to monitor some components (R2min = 0.72). These models were developed 
with simultaneous variation of other components and, for that reason, presented higher 
prediction error than previous work (R2min = 0.95), which enhanced the importance of good 
calibration design. In general, the models developed were robust against interference by the 
other ingredients being studied, demonstrating good specificity, which is a good indicator of 
their utility as a PAT tool. Nevertheless, the prediction of some components proved to be 
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affected by the concentrations of other components. This was the case with riboflavin 
prediction by LIF, which appeared to be impacted by ascorbic acid, probably due to high 
concentration of the vitamin in the mixture (dilution factor). The presence of color 
components could also change prediction when monitored by LIF. Therefore, when 
implementing these monitoring tools, it is important to investigate possible interactions that 
could occur, especially when more than one color component is present (especially important 
in the case of RGB and LIF) and/or if the mixture has more than 1 fluorescent component in 
its constitution. As in this work, a concentration range must be studied, since varying levels of 
interfering components differentially affect prediction of the ingredient to be monitored. 
The present work demonstrates the importance of robust design, and even in complex 
blends, there is potential to use these tools as monitoring instruments, especially when a larger 
acceptance interval criterion is tolerated, as is the case with commercial multivitamin 
formulations. This outcome may potentially apply to these tools as a complement or even as a 
replacement of traditional quantification techniques in such formulations and to show that 
their specificity is reasonable, even in complex mixtures. 
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CHAPTER 6 CONCLUSION 
Due to the changes in the regulatory environment and the benefits provided by the 
implementation of PAT, the use of this technology is becoming more common in the 
development of new products and monitoring of known processes. In fact, its use as a 
monitoring technique to control the manufacturing processes of existing products is being 
reported in literature more often in recent years. Therefore, the most common steps of 
manufacturing processes (blending, granulation, drying, coating) have been the subject of 
most these studies. On the other hand, although tablets are the most common pharmaceutical 
dosage form, monitoring of the compression stage has not been the subject of many studies, 
especially with non-spectroscopical tools. 
This work demonstrates the possibility to monitor in-line the compression stage using 
three different tools (NIR, RGB camera and LIF) under the defined conditions. After an initial 
study with a simple blend to assess the potential of these tools and to evaluate the proposed 
set-up, these tools were used to monitor the constitution of a multicomponent powder flowing 
in the feed frame. Results demonstrated their ability to monitor the selected components in the 
proposed blend under the conditions defined, including a low dosage component in which LIF 
demonstrated a significant accuracy. It was also investigated the advantages of combining data 
from the tools in place. Results show that data combination has a beneficial effect in the 
component prediction as it increases the model accuracy. This finding might lead 
manufacturers to apply more than one tool to monitor their processes in cases where the 
accuracy is not guaranteed by only one tool or in cases where more than one CQA / CPP 
(quantification of another component, for example) is intended to be monitored. 
A further study performed off-line, reinforced the applicability of these tools to be used as 
monitoring tools, as robust models were developed from two full factorial designs based on 
variation of concentration of four components. Although the accuracy of these models might 
be adequate for these type of products (multivitamins, classified as dietary products) their 
prediction values would not be adequate for pharmaceutical products, especially those with a 
narrow therapeutic margin whose reliability is very much needed. On the other hand, the 
formulation tested represented an extreme case due to their large number of components, 
which is hardly found in pharmaceutics. Therefore, the potential and applicability of these 
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tools to monitor a process, especially the compression stage of pharmaceutics is clearly 
demonstrated in this project. However, it must be stated that the specificity of the blends 
(powder properties) and the operating parameters (paddle and die speed) affect the model 
developed and must be tested prior to any implementation. 
The knowledge obtained in this project opens the possibility to use these tools to monitor 
the tablet press as long as the features of the tools are appropriate to the components to track. 
The effective monitoring of components in the tablet press also provides resources to study 
and detect undesired phenomena such as segregation, which is especially important in 
formulations whose properties enhance this possibility. In this sense, further studies should 
direct their focus in tracking components present in formulations known to be segregative in 
order to study this effect in the feed frame and to optimize the operating conditions (number 
and shape of paddles, feed frame speed) that can reduce this effect. 
In terms of component quantification to complement and eventually to replace the 
traditional UDU test, it is critical to develop a robust model. Further studies should focus on 
developing and testing robust models (with an adequate DoE) while changing the operating 
conditions (feed frame speed, for instance). The variability of the operating conditions must be 
evaluated in the validation of the model, to guarantee that a reliable measurement is obtained 
and to prove to the regulatory agencies that whole sets of variability have been included in the 
development. Screening of possible interactions should be studied in order to guarantee the 
specificity. Moreover, the possibility of combining the tools must be assessed and other tools 
that have been successfully used in other applications (Raman spectroscopy, chemical 
imaging) can also provide a significant output of real time press monitoring. 
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 Conclusion en français 
En raison de l'évolution de l'environnement réglementaire et des avantages livrés par la 
mise en œuvre de la PAT, l'utilisation de cette technologie devient de plus en plus courante 
dans le développement de nouveaux produits et dans le suivi de procédés existants. En fait, 
son utilisation comme technique pour contrôler les procédés de fabrication des produits 
existants a davantage été rapportée dans la littérature au cours des dernières années. Par 
conséquent, les étapes plus courantes des procédés de fabrication (mélange, granulation, 
séchage, revêtement) ont fait l'objet de la majorité de ces études. D'autre part, bien que les 
comprimés soient de la forme galénique la plus courante, la surveillance de l'étape de 
compression n'a pas fait l'objet de nombreuses études, notamment avec des outils non 
spectroscopiques. 
Ce travail montre la possibilité de surveiller en ligne l'étape de compression en utilisant 
trois outils différents (NIR, caméra RGB et LIF) dans des conditions définies. Après une étude 
initiale avec un mélange simple pour évaluer le potentiel de ces outils et évaluer le montage 
proposé, ces mêmes outils ont été utilisés pour surveiller la constitution d'une poudre 
multicomposante s'écoulant dans le cadre d'alimentation. Les résultats ont démontré la 
capacité des outils à surveiller les composants choisis dans le mélange proposé, dans les 
conditions définies, y compris un composant à faible dosage dans lequel la LIF a démontré 
une précision significative. On a également étudié les avantages de combiner les données des 
outils en place. Les résultats montrent que la combinaison de données a un effet bénéfique 
dans la prédiction des composants, car elle augmente la précision du modèle. Cette 
constatation pourrait amener les fabricants à appliquer plus d'un outil pour surveiller leurs 
processus dans les cas où l'exactitude n'est pas garantie par un seul outil ou dans le cas où plus 
d'un CQA / CPP (quantification d'un autre composant, par exemple) doit être surveillé. 
Une autre étude réalisée hors ligne a renforcé l'applicabilité de ces outils pour des fins de 
contrôle, car des modèles robustes ont été développés à partir de deux modèles factoriels 
complets basés sur la variation de concentration de quatre composantes. Bien que la précision 
de ces modèles puisse être adéquate pour ces types de produits (multivitamines, classés 
comme produits diététiques), leurs prédictions ne seraient pas adéquates pour les produits 
pharmaceutiques, en particulier ceux dont la marge thérapeutique est faible et dont la fiabilité 
est très nécessaire. D'autre part, la formulation testée représentait un cas extrême en raison de 
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leur grand nombre de composants, ce qui est peu probable dans une formulation 
pharmaceutique typique. Par conséquent, le potentiel et l'applicabilité de ces outils pour 
surveiller un processus, en particulier l'étape de compression des produits pharmaceutiques, 
est clairement démontré dans ce projet. Cependant, il faut préciser que la spécificité des 
mélanges (propriétés de la poudre) et les paramètres de fonctionnement (vitesse de la pale et 
de la matrice) affectent le modèle développé et doivent être testés avant toute mise en œuvre. 
Les connaissances acquises dans ce projet ouvrent la possibilité d'utiliser ces outils pour 
contrôler la presse à comprimés aussi longtemps que les caractéristiques des outils sont 
appropriées aux composants à suivre. La surveillance efficace des composants dans la presse à 
comprimés fournit également des ressources pour détecter des phénomènes indésirables tels 
que la ségrégation, ce qui est particulièrement important pour les formulations dont les 
propriétés améliorent cette possibilité. Dans ce sens, d'autres études devraient être orientés 
vers le suivi des composants présents dans les formulations connues pour être ségrégatives, 
afin d'étudier cet effet dans le cadre d’alimentation et d'optimiser les conditions de 
fonctionnement (nombre et forme des palettes, vitesse du cadre d’alimentation) qui peuvent 
réduire cet effet. 
En termes de quantification de composants pour compléter et éventuellement remplacer le 
test UDU traditionnel, il est essentiel de développer un modèle robuste. D'autres études 
devraient se concentrer sur le développement et l'essai de modèles robustes (avec un DoE 
adéquat) tout en changeant les conditions de fonctionnement (vitesse d'avance, par exemple). 
La variabilité des conditions de fonctionnement doit être évaluée lors de la validation du 
modèle afin de garantir une mesure fiable et de prouver aux organismes de régulation que des 
ensembles complets de variabilité ont été inclus dans le développement. Le criblage des 
interactions possibles doit être étudié afin de garantir la spécificité. En outre, la possibilité de 
combiner les outils doit être évaluée et d'autres outils qui ont été utilisés avec succès dans 
d'autres applications (spectroscopie Raman, imagerie chimique) peuvent également fournir 
une prédiction signification de la formulation d’un comprimé à la sortie de la presse.
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ANNEXES 
A.1 CALCULATION OF THE MASS ANALYZED 
 NIR 
The volume of the material analyzed depends on the integration time set for the probe 
(and the number of samples averaged), distance of the probe to sample, feed frame speed and 
penetration depth (which depends on cohesion properties of the powder). 
 
 Integration time 
The integration time set for this probe was 50 ms (1 000 µs × 50 samples). 
 
 Distance of the probe to sample 
Probe size is 1.5 × 0.4 cm (red arrows, Figure A.1) 
 
Figure A.1: NIR probe dimensions 
 
Previous tests demonstrated that at a distance of 11 mm to the sample (as the setup in 
chapter 3), the probe detects a range up to 2.5 cm, which means that at this distance, the 
probes has a spot size of 2.5 cm × 1.4 cm (0.5 cm more for each side). 
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 Feed frame speed 
The speed of the feed frame was set to 20 rpm in the trial described in chapter 4. 
 Therefore, taking into account the radius (r) of the feed frame (Figure A.2): 
 
Figure A.2 : Feed frame radius  
r = 11.75 cm 
P = 2 ×𝜋×𝑟 = 73.8 cm 
 
Since the feed frame is constituted by 10 paddles, the outer circular sector (l) between two 
paddles is 7.38 cm.  
However, the probe is not located in the outer edge and the powder moves differently 
according to its radial position in the feed frame. Therefore, it is necessary to calculate the 
sectional distance at each of the probes’ edge. Taken into account the position of the probe 
(between radius 10.75 and 8.25 cm): 
Pouter edge = 2 ×𝜋×10.75 = 67.5 cm → 6.75 cm (sectional distance between paddles) 
Pinner edge = 2 ×𝜋×8.25 = 51.8 cm → 5.18 cm (sectional distance between paddles) 
 
r 
l 
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With a speed of 20 rpm, it takes 0.3 seconds = 300 ms for a paddle to course the space 
between paddles. With an integration time of 50 ms for NIR, the distance covered in the 
circular section of each edge is: 
𝐷𝑜𝑢𝑡𝑒𝑟 𝑒𝑑𝑔𝑒 =  
50 𝑚𝑠
300 𝑚𝑠
 × 6.75 𝑐𝑚 = 1.13 𝑐𝑚 
 
𝐷𝑖𝑛𝑛𝑒𝑟 𝑒𝑑𝑔𝑒 =  
50 𝑚𝑠
300 𝑚𝑠
 × 5.18 𝑐𝑚 = 0.86 𝑐𝑚 
 
Figure A.3: Scheme of feed frame wheel with NIR probe and its acquisitions sizes (in cm) 
 
  
 
121 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4: Acquisition area of the probe  
 
Therefore, the total area of analysis (TAREA) of the probe, represented in Figure A.4 is: 
TAREA = A + B 
Since: 𝐴 = 2.5 𝑐𝑚 ×1.4 𝑐𝑚 = 3.50 𝑐𝑚2 
𝐶𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎 =
𝑟 ×𝑙
2
 
𝐵 = 𝐷 − 𝐶 =
10.75 𝑐𝑚 ×1.13 𝑐𝑚
2
−
8.25 𝑐𝑚 ×0.86 𝑐𝑚
2
= 2.52 𝑐𝑚2 
𝑇𝐴𝑟𝑒𝑎 = 3.50 + 2.52 = 6.02 𝑐𝑚
2 
 
B 
C 
A 
D 
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 Depth 
The depth of the equipment for free flowing powders (as it is the case), is assumed to be 
around 1 mm = 0.1 cm. 
 
 Mass calculation 
An observation taken by NIR in this experiment was able to quantify a volume of:  
Tvolume = 6.02 𝑐𝑚2×0.1 𝑐𝑚 = 0.602 𝑐𝑚3 
 
Taking into account the bulk density of the powder for this experiment (0.81 g/cm3), the 
mass analyzed for each observation was equal to: 
𝑚𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑 = 0.810×0.602 = 0.488 𝑔 
 
 LIF 
In the case of LIF, since it is a contact probe, the acquisition size is the same as the probe 
size (0.4 cm diameter). Therefore, the volume analyzed by LIF only depends on the probe 
size, integration time, feed frame speed and penetration depth. 
 
 Integration time 
The integration time set for this probe was 80 µs (1 sample). 
 
 Feed frame speed 
As mentioned, the feed frame speed was set to 20 rpm. 
 
Taken into account the position of the probe (between radius 10.5 and 10.1 cm): 
Pouter edge = 2 ×𝜋×10.5 = 67.5 cm → 6.60 cm (sectional distance between paddles) 
Pinner edge = 2 ×𝜋×10.1 = 51.8 cm → 6.35 cm (sectional distance between paddles) 
 
With an integration time of 80 µs = 0.08 ms for NIR, the distance covered in the circular 
section of each edge is: 
𝐷𝑜𝑢𝑡𝑒𝑟 𝑒𝑑𝑔𝑒 =  
0.08 𝑚𝑠
300 𝑚𝑠
 × 6.60 𝑐𝑚 = 0.002 𝑐𝑚 
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𝐷𝑖𝑛𝑛𝑒𝑟 𝑒𝑑𝑔𝑒 =  
0.08 𝑚𝑠
300 𝑚𝑠
 × 6.35 𝑐𝑚 = 0.002 𝑐𝑚 
 
Therefore, it can be considered that the acquired area for the LIF corresponds to the 
size of its probe: 
ALIF = Π×0.22 = 0.13 cm2 
 
 Depth 
The depth of the equipment for free flowing powders (as it is the case), is assumed to be 
around 1 mm = 0.1 cm. 
 
 Mass calculation 
An observation taken by LIF in this experiment was able to quantify a volume of:  
Tvolume = 0.130 𝑐𝑚2×0.010 𝑐𝑚 = 0.0013 𝑐𝑚3 
 
Taking into account the density of the powder for this experiment (0.81 g/cm3), the mass 
analyzed for each observation was equal to: 
𝑚𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑 = 0.810×0.0013 = 0.0011 𝑔 
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A.2 DATA MINING - NIPALS 
 
Algorithm description: 
1. Choose a start t; 
2. Calculate p (p = XT.t / (tT.t)); 
3. Normalize p (p→ ||p|| = 1) 
4. Calculate t (t = X.p / (pT.p)); 
5. Calculate the residual matrix (E = X - t.pT) 
 
 
                                                                                                  Figure A.5: Algorithm of NIPALS 
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